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Abstract 
Globalization has resulted in closer integration of economies and societies. It has contributed to 
the emergence of a new world order which involves a vast nexus of global and regional 
institutions, surrounded by transnational corporations, and non-governmental agencies seeking to 
influence the agenda and direction of international public policy. Health is a center point of 
geopolitics, security, trade, and foreign policy. Expansion in the territory of health and an 
increase in the number of health actors have profound implications for global health governance. 
Accordingly, the focus of the thesis is on endorsing the three core elements of governance 
proposed by Ackleson and Lapid, which comprises a system of (formal and informal) political 
coordination—across multiple levels from the local to the global—among public agencies and 
private corporations seeking to accomplish common goals and resolve problems through 
collective action. This shift in global governance has been prominent in the health sector with the 
formation of numerous public-private partnerships, coalitions, networks, and informal 
collaborations. In an effort to cope with the proliferation of players in the health sector, the 
World Health Organization has undergone gradual transformation in its governance framework.  
It is important to examine the evolution of the governance architecture of the WHO, as well as its 
effective application in the current global environment maintaining the organization’s 
legitimacy. This study tries to offer a comprehensive account of the WHO’s history, its successes 
and failures, as well as challenges and opportunities confronting the organization. Embracing 
public-private partnerships and formal-informal interactions does not simply fill governance gaps 
opened by globalization, but helps cluster in narrower areas of cooperation, where the strategic 
interests of multilateral organizations (e.g., the WHO), states, and transnational actors intersect. 
Global health problems require global solutions, and neither public nor private organizations can 
solve these issues on their own. The forms of governance based on the Acklesonian-Lapidian 
definition assist in accomplishing public health goals through shared decision-making and risk 
taking. 
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Chapter 1 - Introduction 
 Introduction 
In health, global governance is changing in response to the globalization of diseases, 
shifting power structures of the government, and security concerns in a politically unstable 
world.1 The international organizations have begun to weaken, giving more authority to 
commercial sectors in global health.2 Health systems governance is currently a critical concern in 
many countries because of increasing demand to demonstrate results and accountability in the 
health sector, at a time when more resources are being put into health systems.3  
Governance, which refers to the interactions between various sectors of society, can be 
implemented at various levels ranging from corporate and international to national and local.4 
For the smooth functioning of any undertaking or organization, good governance is a necessary 
foundation. The ability to coordinate the necessary actions (amongst public and private 
stakeholders) is reflective of effective governance and is especially important when a country 
faces security threats that could negatively affect the nation's economy and civil society. With 
the growth of civil society and enormous new funding for global health from the private sector, 
new concepts of governance involving a large number of non-state actors are needed. Effective 
governance often involves international cooperation. Different models of international 
                                                 
1
 Health is defined by the WHO “as a state of complete physical, mental, and social well-being and not merely the 
absence of disease or infirmity.”World Health Organization, "Constitution of the World Health Organization," (New 
York: United Nations, 1946). Public health is the science and art of preventing disease, prolonging life and 
promoting health through the organized efforts and informed choices of society, organizations, public and private, 
communities and individuals."C. E. A. Winslow, "The Untilled Fields of Public Health," Science 51, no. 1306 
(1920). 
2
 Thomas E. Novotny, "Global Governance and Public Health Security in the 21st Century," California Western 
International Law Journal 38, no. 19 (2007). See page 19. This article is based on a speech given by the author at 
the Weaver Center at the Institute of the Americas in University of California, San Diego on 26 October 2006. 
Global health is the health of populations in a global context and transcends the perspectives and concerns of 
individual nations. Theodore M. Brown, Marcos Cueto, and Elizabeth Fee, "The World Health Organization and the 
Transition From "International" To "Global" Public Health," American Journal of Public Health 96, no. 1 (2006). 
3
 Sameen Masud Siddiqi et al., "Framework for Assessing Governance of the Health System in Developing 
Countries: Gateway to Good Governance," Health Policy 90, no. 1. A health system can be defined as the structured 
and interrelated set of all actors and institutions contributing to health improvement. The health system boundaries 
could then be referred to the concept of health action, which is "any set of activities whose primary intent is to 
improve or maintain health."C. J. L. Murray, "A Framework for Assessing the Performance of Health Systems," 
Bulletin of the World Health Organization 78, no. 6 (2000). 
4
 UNESCAP, "What is Good Governance ?,"  available at 
http://www.unescap.org/pdd/prs/ProjectActivities/Ongoing/gg/governance.asp. 
2 
cooperation that can be embraced include transgovernmental networks (TGNs), which are made 
up of sub-state level officials rather than the heads of state, and transnational networks 
(TNNs), which are made up of private actors such as non-governmental organizations and 
business representatives.5 Project researchers6 have identified historical and contemporary cases 
in which governance—particularly as it relates to TGNs and TNNs—may be studied. These 
cases include the International Sanitary Conference (ISC) of 1851 and the recent international 
trade policy concept of compartmentalization.7  
The ISC of 1851 is an example of the presence of TGNs in the realm of public health 
security. In 1832, pandemic cholera, which is spread via water, caused 21,000 deaths in Paris 
alone. The first ISC was convened only in July 1851. The representatives who attended were not 
only the chiefs of government from across Europe, but also lower-level officials, physicians, and 
sanitation authorities who came together to discuss communicable diseases.8 There were ten 
ISCs convened 1851 onwards. When studied together, the ISCs offer an historical perspective on 
TGN involvement in the realm of public health security. The delegates from various 
governments were responsible for reporting the decisions made at the conferences to their 
governments for future implementation. No treaties or formal agreements were made at the 
International Sanitary Conferences; the functionality of the International Sanitary Conferences 
relied on the governments’ cooperation in adopting the policies that were discussed.9 The ISCs 
can be considered the first efforts at policy convergence to forge international law that would 
bring balance to international trade and health objectives.10 The link between international trade 
agreements and international public health deserves more attention than it has received to date. 
There are various challenges facing global public health systems and trade. The health sector is 
one such area that has been significantly affected by globalization, despite its image as a global 
                                                 
5
 Mette Eilstrup-Sangiovanni, "Varieties of Cooperation: Government Networks in International Security," in 
Networked Politics (2009). 
6
 In the FIX (Frontier Interdisciplinary eXperience) Program, Dr. Justin Kastner, other students, and the author of 
the thesis work in this area of research. 
7
 The author’s major professor, Dr. Justin Kastner, has a long-term interest in this area.  
8
 Valeska Huber, "The Unification of the Globe by Disease? The International Sanitary Conferences on Cholera, 
1851–1894," The Historical Journal 49, no. 2 (2006). 
9
 WHO, "International Sanitary Conferences," in The First Ten Years of the World Health Organization (Geneva: 
1958). 
10
 Norman Howard-Jones, "The Scientific Background of the International Sanitary Conferences 1851–1938," WHO 
publications (1975). 
3 
public good (GPG).11 Such GPGs cannot be supplied by a single institution or government. Thus 
governments and public agencies have come together with NGOs and the private sector to 
establish transnational structures (partnerships, treaties or agreements) to address the supply of 
GPG and reduction of global public bads.12 
The facilitation of smooth, unhindered trade requires superior public health systems. The 
manner in which public health and global trade can work together is through the creation of 
international networks. This implies the need for transnational cooperation of actors in the area 
of trade, economics, healthcare, and public health. Compartmentalization is a novel, 
internationally endorsed policy tool used to facilitate safe trade. It involves governments and 
companies certifying the biosecurity of specific animal herds and food supply chains. TGNs and 
TNNs must work together in order to implement the concept of compartmentalization, which 
allows for “biosecure compartments” to continue to export even if other establishments or 
geographical areas have food safety or biosecurity problems.13 The costs of global diseases, 
including damage from responses to such threats and restricted trade flows, have made countries 
more aware of these problems as a matter of special concern for their national interest.14 The 
management and coordination of all these players requires the incorporation of principles of 
good governance into a network’s working routine. In order to develop policies and programs for 
issues encompassing health, trade, and commercial interests, the role of the private sector should 
be considered especially critical for networks that are transnational in nature.15 Therefore, it is 
vital to evaluate the role of TGNs and TNNs in public health and trade security.  
 History of international health security   
The contemporary system of international health surveillance, monitoring, and sanitary 
regulations did not exist until the 19th century. In spite of this, there is substantial information 
available regarding the public health capacity of the pre-19th century societies of the 
Mediterranean and the Middle-East. Many civilizations in these regions were ahead of their 
                                                 
11
 David Dollar, "Is Globalization Good for Your Health?," Bulletin of the World Health Organization 79(2001). 
12
 Richard G. A. Feachem, "The Role of Governments," in Critical Issues in Global Health, ed. Charles Everett 
Koop, Clarence E. Pearson, and M. Roy Schwarz (San Francisco, CA: Jossey-Bass, 2001). 
13
 A. Scott et al., "The Concept of Compartmentalisation," Rev. sci. tech. Off. int. Epiz. 25, no. 3 ( 2006). The idea of 
collaborative work between different actors (from both the government and the private industry) at national and 
international levels is crucial to compartmentalization. 
14
 David P. Fidler, "Vital Signs," The World Today, February 1 2009. 
15
 Eilstrup-Sangiovanni, "Varieties of Cooperation: Government Networks in International Security." 
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times in the fields of architecture, planning, and engineering, a fact that is evident from the 
remains of their water supply systems, drainage, and garbage disposal systems. They had 
knowledge about the causal factors for certain diseases and had tools to address those problems. 
In the case of Europe, it was a slightly different story. Medieval Europe trailed in scientific 
technologies, ideas, and practices in comparison with their Persian counterparts. The European 
continent was in pursuit of power and riches, which led its merchants to conquer resources and 
land in other parts of the world, thereby increasing travel and movement. The congested towns of 
Europe were a perfect set-up for disease outbreaks. The middle ages witnessed two massive 
plague outbreaks. In 542 AD, the pandemic Plague of Justinian decimated populations from Asia 
to Europe. In order to protect their citizens, governments of affected nations imposed quarantine 
on ships and persons suspected of carrying the disease. There was no official system of 
notification or cooperation between city-states. There was a unilateral arrangement to impose 
quarantine within respective countries rather than a multilateral one.16 The spread of plague was 
suspected to be through human contact, especially introduced via ships leading to some of the 
earliest attempts at international disease control via “quarantine.”17 
Today’s global health system evolved through two general periods: the 19th to mid 20th 
century, and the mid 20th to the early 21st century. European industrialization gave rise to a 
complex set of needs related to the new-found importance of the health of workers and the 
general population. The need of the hour was to have uninterrupted trade that was free from 
disease outbreaks.18 The emergence of a link between international law and communicable 
diseases is rooted in the mid-19th century. In 1851, France convened the first International 
Sanitary Conference (ISC),19 and then from 1851 to the end of the 19th century, ten such 
conferences were convened. Eight sanitary conventions were negotiated on the subject of cross-
                                                 
16
 Anne-Emanuelle Birn, Pillay Yogan, and Holtz Timothy, Textbook of International Health: Global Health in a 
Dynamic World, 3rd ed. (Oxford University Press, 2009). p17- 24. Quarantine that dates back to 1377 was strictly 
pertaining to plague, when the Rector of the seaport of Ragusa (then belonging to the Venetian Republic) officially 
issued a 30-day isolation period for ships. Recently, the term quarantine has come to indicate a period of isolation 
imposed on persons, animals, or things that might spread a contagious disease. Gian Franco Gensini, Magdi H. 
Yacoub, and Andrea A. Conti, "The Concept of Quarantine in History: From Plague to SARS," Journal of Infection 
49, no. 4 (2004). p257-261 
17
 Aginam Obijiofor, Global Health Governance : International Law and Public Health in a Divided World 
(Toronto: University of Toronto Press, 2005). pp946-951 
18
 Alison Bashford, Imperial Hygiene: A Critical History of Colonialism, Nationalism and Public Health 
(Houndmills and New York: Palgrave Macmillan, 2004). 
19
 WHO, "International Sanitary Conferences." pp3-5 
5 
border spread of cholera, plague, and yellow fever across the geopolitical boundaries of 
(European) nations, and, within the Americas, the 1905 Inter-American Sanitary Convention 
imposed notification duties for cases of cholera, plague, and yellow fever. In 1924, the Pan-
American Sanitary Code provided for bi-weekly notification of ten specific diseases and any 
other diseases that the Pan-American Sanitary Bureau might add, and also provided for 
immediate notification of plague, cholera, yellow fever, smallpox, typhus, or any other 
dangerous “contagion” liable to spread through international commerce.20 The World Health 
Organization (WHO), established on 7 April 1948 and headquartered in Geneva, Switzerland, 
was created as the first specialized agency under the United Nations with the sole objective of 
international health co-operation and unification. Article 21 of the WHO constitution delegates 
the authority to adopt regulations concerning, among other things, procedures like sanitation, 
quarantine, and others designed to prevent the international spread of disease.21 In 1969, as part 
of the revision effort, the World Health Assembly renamed the ISC, calling it the International 
Health Regulations (IHR). The IHR, signed by the 194 member states, provided a unified code 
for infectious disease control. Due to various drawbacks and shortcomings in the IHR, the WHO 
proposed its revision in 1998, a process that took almost 7 years to complete. The revised draft 
was eventually presented and accepted in 2005. 22,23  
Trade, like health systems, went through a series of transitions. A number of multilateral 
agreements were put in place to facilitate trade between countries. The barter system, which goes 
back for centuries, could easily be considered the primary factor behind a country’s willingness 
to initiate interaction with other countries. The barter system started the dialogue process 
between countries, and eventually evolved into the current international trade agreements. 
During the period of reconstruction following World War II, the “Bretton Woods” accords 
helped stimulate economic growth in Europe and Japan by stabilizing inflation and facilitating 
                                                 
20
 The interest of governments in international health and the spread of diseases across borders led to the formation 
of many international health agencies. The agencies will be discussed in detail in chapter 3 of this thesis. Obijiofor 
Aginam, "International Law and Communicable Diseases," Bulletin of the World Health Organization 9(2002). 
pp946-947 
21
 The WHO Constitution, art. 21 
22
 The World Health Assembly is the decision-making body of the WHO. It is attended by delegations from all the 
WHO Member States and focuses on a specific health agenda prepared by the Executive Board. The main functions 
of the World Health Assembly are to determine the policies of the WHO, appoint the Director-General, supervise 
financial policies, and review and approve the proposed program budget. WHO Media centre, "World Health 
Assembly," WHO, available at http://www.who.int/mediacentre/events/governance/wha/en/index.html. 
23
 WHO, "International Health Regulations (IHR)," ed. World Health Organization (Geneva: WHO, 2005). (2005) 
6 
formulation of trade agreements. Further negotiations, which took place from 1944 to 1947, led 
to the establishment of the International Monetary Fund (IMF), the World Bank, and the General 
Agreement on Tariffs and Trade (GATT).24,25 The World Trade Organization (WTO) replaced 
the GATT in 1995. The functions of the WTO include administering WTO trade agreements, 
handling trade disputes between nations and monitoring national trade policies, and acting as a 
forum for trade negotiations. With the establishment of the WTO, the IHR, and other multilateral 
organizations and agreements, the world has witnessed pronounced globalization. Globalization 
is a process that is changing the nature of human interaction across a wide range of spheres and 
dimensions.26 The disparity between the developed and developing world has led to intractable 
South-North animosity in most multilateral institutions, including the WHO. The onset of the 
21st century witnessed an accelerated polarization of the world less by geo-political boundaries 
and ethno-cultural affinities and more by poverty and under-development.  The gap between the 
developed and developing world is widening.  According to the WHO, poverty is the world’s 
most ruthless killer and is the greatest cause of ill-health and physical suffering.27  
 Globalization and governance 
As the title of Thomas L. Friedman’s book rightly puts it, The World is Flat. Owing to 
the phenomenon of globalization, the world is getting “smaller” each day. He defines 
globalization as “the inexorable integration of markets, nation-states, and technologies to a 
degree never witnessed before—in a way enabling individuals, corporations, and nation-states to 
reach around the world farther, faster, and by cheaper means than ever before.”28 Increased 
globalization and travel has facilitated a greater mixing of cultures, customs, and ideas, as well as 
a rapid cross-border flow of goods, services, people, and capital. Some might argue that 
globalization has also resulted in new security threats, greater global health problems, increased 
                                                 
24
 The “Bretton Woods” agreement, signed in July 1944, created the Bretton Woods financial system. It was based 
on stable and adjustable exchange rates.  The system established a gold standard that required a commitment from 
each country to maintain a fixed value for the exchange rate of its currency in terms of gold. I. Yotov, The Quarters 
Theory: The Revolutionary New Foreign Currencies Trading Method (Hoboken, NJ: John Wiley & Sons, 2009). See 
page 53 
25
 Ellen R. Shaffer et al., "Global Trade and Public Health," American Journal of Public Health 95, no. 1 (2005). 
26
 K. Lee, "For Debate. The Impact of Globalization on Public Health: Implications for the UK Faculty of Public 
Health Medicine," Journal of Public Health 22, no. 3 (2000). 
27
 Lincoln Chen, Jennifer Leaning, and Vasant Narasimhan, Global Health Challenges for Human Security 
(Cambridge: Harvard University Press, 2003).P 54 
28
 T.L. Friedman, The Lexus and the Olive Tree (New York: Farrar, Straus, Giroux, 2000). P 9 
7 
economic disparity, and fragmentation of power.29 The links between globalization and health 
are complex and the consequences of globalization (both good and bad) impact every segment of 
the world’s population. The threat of misuse of globalized information for bioterrorism purposes 
is becoming a serious concern for many governments. On the other hand, globalization has also 
resulted in some gains for the health sector. One such gain has been the advent and proliferation 
of information technology. Improvements in information technology have dramatically increased 
the speed and ease of data flow, speeding up clinical research, and facilitating the sharing of 
information across borders and continents.30 While it is uniformly believed that poverty and 
under-development breed disease, assessing the actual impact of globalization on public health 
remains controversial. Globalization enables disease-causing pathogens to transcend boundaries 
with ease. The process of globalization and subsequent vulnerability of national borders have 
altered the traditional distinction between national and international health.31 Globalization has 
impacted the health status and altered the policy-making abilities of many countries worldwide. 
Opponents of globalization have argued that states will have little opportunity to exercise their 
powers in a global environment that is now mostly shaped by private actors.32 The unimaginable 
increase in interconnectedness between social and economic sectors has led to new, as well as re-
emerging health threats like Severe Acute Respiratory Syndrome (SARS) and avian 
influenza.33,34 Trade barriers are also disappearing, which means that populations have increased 
chances of exposure to infectious diseases from every possible corner of the world. Global trade 
will continue to thrive and expand with improvements in transportation, infrastructure, marketing 
networks, and per-capita income levels. As a result of this expansion, consumers in developed 
countries are demanding more rigorous health standards. The changing conditions of global trade 
have raised important challenges for public health: privatization of public services; reduced 
                                                 
29
 One cannot disregard either of these viewpoints; there is some validity in both of them. D. Yach and D. Bettcher, 
"The Globalization of Public Health I: Threats and Opportunities," American Journal of Public Health 88, no. 5 
(1998). 
30
 Tikki Pang and Emmanuel G. Guindon, "Globalization and Risks to Health," EMBO reports 5, no. S1 (2004). 
31
 Obijiofor, Global Health Governance : International Law and Public Health in a Divided World. 
32
 W. H. Reinicke and J. M. Witte, Interdependence, Globalisation and Sovereignty: The Role of Non-Binding 
International Legal Accords (Oxford Univeristy Press, 1999). 
33
 Andrew Cooper and John Kirton, Innovation in Global Health Governance: Critical Cases (Burlington, VT: 
Ashgate Publishing Ltd, 2009). P 4  
34
 There is a high probability of encountering risk factors for chronic diseases too, especially through marketing of 
unhealthy products like tobacco and junk food. This diminishes public health standards in many ways. In the age of 
closer boundaries and bioterrorism, it is critical to be conscious of the events happening around the world and join 
hands for confronting the challenges associated with the new age.  
8 
sovereignty of governments in regulating services, medications, equipment, and economic 
activities (particularly those that affect occupational and environmental health); and enhanced 
power of multinational corporations and international financial institutions in policy-making.35,36 
Some experts predict that access to healthcare, health related knowledge, and technology will be 
greatly influenced by forces outside national sovereign control.37  
Globalization affects health in a multifaceted manner. The increase in global public- 
private partnerships (GPPPs) can indeed be attributed to globalization. In the 1990s, the health 
sector experienced a tremendous rise in the number of alliances between the United Nations 
(UN) agencies and the private (for-profit) sector.38 This rise is helping to solve some major 
health problems, but at the same time it is likely to weaken the WHO’s authority over health 
worldwide. Today, health systems are policy rich and capacity poor in developing nations. There 
is a dire need for improving and building capacity in order to confront emerging and re-emerging 
diseases and public health security threats.39 The tremendous amount of interaction and 
interdependence between various players requires efficient networking coupled with cooperation 
and planning in the form of good transnational governance. Governance is not the same as 
government.40 It is a continuous process followed and coordinated by multiple state and non-
state actors, or public and private sector associates. There are different levels at which 
governance is vital. Governance pertains to varied sorts of collective behavior ranging from local 
community groups to transnational corporations, labor unions, and the UN Security Council. 
Governance relates to the combination of public and private spheres of human activity. The 
                                                 
35
 Shaffer et al., "Global Trade and Public Health." See page 33. The author discusses the positives of a trade and 
health partnership. He favors the collaborated method of formulating agreements.  
36
 The author of this thesis has profound interest in studying the significance of the various actors engaged in 
ensuring import security. In this context, the author has submitted a manuscript titled “Multiplicity of Actors 
Involved in Securing America’s Food Imports” to the Journal of Homeland Security and Emergency Management 
and the article is currently under review. The article has Colleen Cochran and Dr. Justin Kastner as the second and 
third author respectively. The paper discusses the importance of the need for a collaborated effort of federal 
government and the private industries to ensure food import security in the US. 
37
 R.D.  Smith, "Foreign Direct Investment and Trade in Health Services: a Review of the Literature," Social Science 
and Medicine 59(2004). Foreign insurance companies will be able to offer services within a country and affect both 
the health care sector and the common man. 
38
 K. Buse and G. Walt, "Global Public-Private Partnerships: Part II - What Are the Health Issues for Global 
Governance?," (WHO, 2000). 
39Public health security, which includes food and agriculture security, is defined as the proactive and reactive 
activities required for minimizing the public’s vulnerability to acute public health events that endanger the collective 
health of national populations. World Health Organization, "A Safer Future: Global Public Health Security in the 
21st Century," in The World Health Report 2007 (Geneva: WHO, 2007). Pg 9 
40
 There is a universal misconception that governance is exclusively a government’s responsibility. It should ideally 
involve rigorous thought process and decision making by players from diverse fields and not just the public sector. 
9 
former Secretary-General of the United Nations, Kofi Annan, said, “Good governance is perhaps 
the single most important factor in eradicating poverty and promoting development.”41 This is an 
apt reflection of a dire need of good governance in today’s global context.42 The following 
definition, articulated by Drs. Jason Ackleson and Yosef Lapid, best describes the complex 
structure of governance as:  
“Policy actions which are the result of a process which involves both 
formal and informal actions, coordination, and management by different 
political, economic, and social actors – in addition to governments. These 
actions occur on multiple levels, such as the international, national, 
regional, and local.”43  
Partnerships are essential in the contemporary world, as the problems we face require 
multisectoral, multidisciplinary, and multicomponent efforts.44 There are several health-related 
PPPs in existence, including the STOP TB initiative, the Multilateral Initiative on Malaria, the 
Global Alliance for Vaccines and Immunization (GAVI), the Mectizan Donation Program 
(MDP), Healthy Cities and Health 21, and the Global Fund for AIDS, TB, and Malaria among 
others. These PPPs aid in fund allocation, research and development, and medical supply 
distribution. Despite these merits, they are known to bring with them problems like poor 
harmonization between stakeholders and national governments, commercialized approaches to 
public health, and intrusion into the public sector.45 Although GPPPs are emerging as a distinct 
form of global governance, little analysis has been done to address these problems.46  
                                                 
41
 Regina Birner, "Improving Governance to Eradicate Hunger and Poverty," in 2020 Focus Brief on the World’s 
Poor and Hungry People (Washington D.C.: IFPRI, 2007). 
42
 S. Siddiqi et al., "Framework for Assessing Governance of the Health System in Developing Countries: Gateway 
to Good Governance," Health Policy 90, no. 1 (2009). P 14  
43
 Dr. Jason Ackleson, June 2010. Washington D.C. During the author’s research visit to D.C. in the summer of 
2010, she met with Dr. Ackleson to gain more insight on the subject of governance. Dr. Ackelson explained the 
definition of governance put forth by Dr. Yosef Lapid and himself at New Mexico State University.  
44
 William C. Richardson and John P. Allegrante, "Shaping the Future of Health through Global Partnerships," in 
Critical Issues in Global Health, ed. Charles Everett Koop, Clarence E. Pearson, and Schwarz M. Roy (San 
Francisco, CA: Jossey-Bass, 2001). In this complex and interdependent global society, promoting the cause of health 
will require a long-term commitment to cooperation among public agencies, private authorities, and nonprofit 
sectors. 
45
 M.R.  Reich, "Public-Private Health Partnerships for Public Health," Nature Medicine 6, no. 6 (2000). 
46
 See page 43 in  Kelley Lee, Kent Buse, and Suzanne Fustukian, Health Policy in a Globalising World 
(Cambridge: Cambridge University Press, 2002). The author of the thesis found insights into examples of various 
GPPPs in operation.  
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There are three categories of health GPPPs:47,48 
1. Product-based partnerships: These are initiated by the private sector and are primarily 
drug donation programs created to increase coverage. Such partnerships are generally 
established after the discovery of an existing drug’s effectiveness (for animals or humans) 
in the treatment of a condition for which there is limited effective demand, due to lack of 
ability to pay. In these partnerships, the private sector seeks to establish political contacts 
and establish a global reputation.  
2. Product-development based partnerships: These are initiated by the public sector and 
focus on pharmaceutical product development for diseases of the developing world. 
These partnerships are not targeted to specific countries and are driven based on market 
failure. Although these products are a worthy investment, the market is unable to allocate 
resources for their discovery and development because their returns are unpredictable. 
PDPs are created for the public good and the resulting products are made affordable to all 
who need them.  
3. Issues/systems based partnerships: These types of partnerships help to overcome market 
failure and bring strategic consistency to the different approaches (from various actors) in 
combating a single disease. Examples include the Roll Back Malaria initiative and the 
STOP TB initiative, among others.  
 
For examples of the types of GPPPs, see Table 1.  
                                                 
47
 K.  Buse and G. Walt, "Global Public-Private Partnerships: Part I-A New Development in Health?," Bulletin of the 
World Health Organization 78, no. 4 (2000). 
48
 Lee, Buse, and Fustukian, Health Policy in a Globalising World. See p 45-47  
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Table 1. Selected examples of global public-private partnerships in health   
Type of GPPP Name/Date Partners & Donors Goal 
Product-based GPPPs 
 
Mectizan Donation 
Program (MDP) 
1987 
 
• Merck & Co. 
• WHO 
• World Bank 
• Task Force on 
Child Survival and 
Development 
• National 
authorities 
• NGOs49  
Eliminate onchocerciasis 
by treating affected 
populations with Mectizan, 
a drug developed by Merck 
& Co.  
Product-development based 
GPPPs 
 
International AIDS 
Vaccine Initiative 
(IAVI) 1999   
 
• National AIDS 
Trust  
• Albert B. Sabin 
Vaccine Institute 
• World Bank 
• UNAIDS 
• GSK 
• Bill and Melinda 
Gates Foundation 
• Rockefeller 
Foundation  
Ensure development of 
safe, preventive, effective, 
and accessible HIV 
vaccines for use throughout 
the world.  
Issues/systems based health  
GPPPs  
 
Roll Back Malaria • WHO, UNICEF, 
UNDP and the 
World Bank, 
• 500 partners that 
are organized in 8  
constituencies, and 
NGOs 
Aims to reduce malaria 
morbidity and mortality by 
reaching universal 
coverage and strengthening 
health systems  
 
 
Sources: Frost, L, and M Reich. "Mectizan Donation Program: Origins, Experiences, and Relationships with Co-
Ordinating Bodies for Onchocerciasis Control." Boston: Harvard School of Public Health, 1998. Buse, K. "Global 
Public-Private Health Partnerships: Part II-What Are the Health Issues for Global Governance?" Bulletin of the 
World Health Organization 78, no. 5 (2000): 699. Lee, Kelley, Kent Buse, and Suzanne Fustukian. Health Policy in 
a  Globalising World. Cambridge: Cambridge University Press, 2002. 
                                                 
49
 The MDP relies on Nongovernmental Development Organizations (NGDOs) to ensure efficient distribution of 
Mectizan. The prominent NGOs include the Carter Center, Charitable Society for Social Welfare (CSSW), Helen 
Keller International (HKI), International Eye Foundation (IEF), Lions Clubs International Foundation (LCIF), and 
United Front against River Blindness (UFAR) amongst others. Mectizan Donation Program, "Partners," MDP, 
available at http://www.mectizan.org/nongovernmental-development-organization-ngdo-partners. 
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Horizontal interaction is needed between research groups, national governments, and 
funders within different countries. It is alarming that only ten percent of research funds are spent 
on diseases that account for 90 percent of the global disease burden. Good governance is 
necessary for ensuring the conduct of ethically sound research, especially in vaccine 
development. The people of Third World nations are thought to benefit from the health research 
carried out by the wealthier nations, but this is not always true.50 Research workers and experts 
have started to migrate from public to private domains and from the developing to the developed 
world, resulting in a process that has been informally dubbed “the brain drain.” This drain on 
human resources limits the developing nations’ ability to participate in political debates, decision 
making, and global health governance; this, in turn, decreases their efficiency and authority in 
policy-making and research.51 Arriving on one single characterized definition of governance is 
difficult, especially as definitions of governance tend to vary according to the objectives of 
organizations. In analyzing the various models of governance put forth by different 
internationally renowned organizations, and analysts, it seems appropriate to have the Ackleson-
Lapid elements as an indispensable part of the governance structure of the different 
organizations’ and projects’ discussed in this thesis. The governance pattern should incorporate 
three core elements engaging in formal-informal policy action, forging public-private 
partnerships, and interacting at multiple levels of society. 
                                                 
50
 Kelley Lee and Anne Mills, "Strengthening Governance for Global Health Research: The Countries That Most 
Need Health Research Should Decide What Should Be Funded," British Medical Journal 321, no. 7264 (2000). 
Kelley and Mills argue that it is unethical to test AIDS vaccines or drugs in countries that cannot afford these 
treatments. 
51
 Chitr Sitthi-amorn et al., "/ Strengthening Health Research Capacity in Developing Countries: a Critical Element 
for Achieving Health Equity / Commentary: Health Research and Human Development in Papua New Guinea / 
Commentary: Does Strengthening Research Capacity Improve Health Equity?," British Medical Journal 321, no. 
7264 (2000).  
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Figure 1. Graphical depiction of the elements of governance 
Note: Public-private partnerships form a vital part of the description, linking the local, national, 
and global levels of governance. Asterisks (*) indicate the key elements of governance, as put 
forward by Ackleson and Lapid, the presence of which are explored in this thesis.52 Julianne 
Jensby, the author’s colleague at K-State and Frontier, helped develop this depiction of the 
elements of governance. For more details, see Table 2.  
 
                                                 
52
 Personal communication with Dr. Jason Ackleson, Washington D.C., June 2010. During the author’s research 
visit to D.C. in the summer of 2010, she met with Dr. Ackleson to gain more insight on the subject of governance. 
Dr. Ackleson explained the definition of governance put forth by Dr. Yosef Lapid and himself at New Mexico State 
University. 
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Research questions, objectives, and methodologies 
Governance is an important facet of the success of any institution, event, or undertaking. 
In order for the different international organizations and networks to function efficiently, they 
should incorporate elements of governance. Applying and incorporating the various attributes of 
governance requires planning, implementation, and critical thinking. With this in mind, the thesis 
poses the following overall research questions: 
1. How do prevailing public health security related international organizations, 
specifically the World Health Organization (WHO) and some of its initiatives, 
exhibit the implementation of the elements of governance?53 
2. How has the implementation of the elements of governance changed over time in the 
WHO? 
The thesis tries to answer these overall questions through the following objectives:  
a. Analyzing the concept of global governance, the reasons for the evolution of different 
governance structures in the WHO, and the impact of these factors in the field of global 
public health in general. 
b. Reviewing the WHO and some its projects and initiatives, in order to ascertain the 
presence or absence of the essential elements of governance (see Table 2) over time. 
c. Illustrating certain examples of models or initiatives wherein the WHO has embraced and 
adopted these elements of governance. 
See Table 2 for a summary of the three essential elements of governance used to guide this thesis 
project. 
 
 
 
 
                                                 
53
 The term “security” needs special mention. Most of the multilateral or bilateral organizations in trade and health 
have been established to achieve security. Security involves many things including preservation of life. Dr. Justin 
Kastner mentioned this in his lecture “Globalization and Food and Agricultural Security,” at Kansas State University 
on 20 May 2010.    
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Table 2. The three essential elements of governance 
Formal & informal  
policy actions 
  Public-private  
partnerships 
  Multiple  
levels 
• Brokered in meetings, 
discussions, and 
forums 
• Brokered by 
individuals from the 
government, the 
private sector, and the 
NGO community 
 
• Bring together at least 
three parties: a 
corporation and/or 
industry association, 
an intergovernmental 
organization, and a 
member of civil 
society 
• Encourage broader 
understanding of—and 
wider range of 
solutions for—global 
issues (e.g., health, 
trade, etc.)  
• May help participants 
to achieve shared goals 
on the basis of a 
mutually agreed upon 
division of labor 
• Involves local, 
national, and 
international levels 
• Facilitates vital 
transnational 
networking and cross-
border relationships  
Note: The elements of governance mentioned are a non-exhaustive list of key elements. These attributes are 
foundational for the smooth implementation of indispensable auxiliary factors like transparency, rule of law, respect, 
and consideration for human rights in the governance structure. 
Conducting case studies is an interesting and useful way to evaluate any concept and its 
application in the real world.54,55,56 Focusing on strengthening the future of public health and 
trade security issues requires incorporation of the elements of governance into the current global 
systems. Inductive reasoning was used to analyze the objectives and answer the research 
questions of this thesis.57,58 Inductive reasoning argues from the specific to the general. The 
                                                 
54
 Case studies are used to organize a wide range of information about a case and then analyze the contents by 
seeking patterns and themes in the data and by further analysis through cross comparison with other cases. Case 
studies are an interesting way of public health research. It is a research strategy that focuses on exploration of a 
complex phenomenon and related context. It helps us to critically think through the background information about a 
particular theory/practice using a working example. Peter Lydyard et al., Case Studies in Infectious Disease 
(Garland Science, 2009). 
55
 Leonard G. Horowitz, "Case Study in the Public Health Menace of Tuberculosis (TB) Testing," Medical Veritas 4 
(2007 ). 
56
 L. J. Mata, The Children of Santa Maria Cauque: a Prospective Field Study of Health and Growth, ed. Costa Rica 
University Institute of Health Research (MIT press, 1978). 
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thesis tries to reiterate that incorporation and appropriate execution of the three elements of 
governance is essential for efficient and successful functioning of any health organization, 
initiative, or project. By taking the approach of institutional history, this thesis tries to analyze 
and evaluate the structure of a major international health institution, the World Health 
Organization (WHO). The thesis further analyzes some selected projects of the WHO (both 
successful and unsuccessful) to discern their effectiveness in implementing elements of 
governance in their working agenda. The thought behind comparing these initiatives with 
contradicting outcomes was to assess the cause for variability in the execution of good 
governance among prominent international organizations. The thesis begins with specific 
observations and measures to detect patterns and regularities among the cases that are explored, 
and eventually develops some general conclusions or theories. Hence, the thesis progresses from 
having a component (the three elements of governance) as the specific factor to eventually 
arriving at the conclusion that there is a positive correlation between success of a health 
organization or initiative and the effective inclusion of the three elements of governance.59  
 World Health Organization 
The WHO, headquartered in Geneva, Switzerland, is a specialized agency of the United 
Nations (UN) that acts as a coordinating authority for international public health. It was 
established on 7 April 1948, and the agency inherited its mandate and resources from its 
predecessor, the Office International d'Hygiène Publique (OIHP).60,61 The WHO has been 
                                                                                                                                                             
57
 Inductive reasoning is one of the two basic forms of valid reasoning. It is of particular importance in qualitative 
research approaches. It seeks to generate general statements based on observations or efforts to develop theory from 
empirical data. LM Given, The Sage Encyclopedia of Qualitative Research Methods (Sage Publications, 2008). It is 
one of the most commonly used research methodologies in the social sciences and also the hard sciences, but one 
must exercise caution while deriving conclusions beyond the original cases or settings. 
58William M.K. Trochim, "Philosophy of Research - Deduction and Induction," in Research Methods Knowledge 
Base (Atomic Dog Publishing, 2006). Most social research involves both inductive and deductive reasoning 
processes at some point in the project.  
59
 Inductive reasoning progresses from observations of individual cases to the development of a generality. It 
follows this order: observation to pattern to tentative hypothesis to theory. In the real world, humans tend to follow 
inductive reasoning. 
60
 World Health Assembly, "Constitution of the World Health Organization," ed. WHO, October 2006 (Geneva 
2006). 
61
 WHO, "Archives of the Office International D'hygiène Publique (OIHP)." The Office International d'Hygiène 
Publique (OIHP) established in Rome on 9 December 1907, was governed by the authority of the Permanent 
Committee composed of delegates technically qualified in the field of health, designated by the member states. The 
Office was dissolved under the protocol provided for OIHP in the agreements signed on 22 July 1946. Its 
epidemiological service was officially transferred to the Interim Commission of WHO on 1 January 1947. 
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instrumental in eradicating smallpox (once among the most feared diseases) and has helped 
contain sanitation-related diseases such as cholera and typhoid, as well as relatively new ones 
such as SARS and HIV. It has led efforts in health-related fields like sanitation, injury 
prevention, and public health, and is currently working to combat tobacco use and chronic 
diseases like cancer and diabetes.62 In 1969, as part of the revision effort, the World Health 
Assembly (WHA) renamed the International Sanitary Regulations, calling it the International 
Health Regulations (IHR). Both the IHR and the Framework Convention on Tobacco Control 
(FCTC) are legal mechanisms used by the WHO to govern global health issues, and the latter is a 
treaty regarding the restrictions of tobacco advertisement, sponsorship, and promotion. This 
helps to crack down on tobacco smuggling too. The IHR’s purpose is “to ensure the maximum 
protection against the international spread of disease with minimum interference with world 
traffic,” an aim that captures the WHO’s core objectives.63 As an organization spanning national 
governments, the WHO also plays an important role in initiating the development of 
international law in health. It has been labeled unsuccessful in many of its efforts, but hugely 
successful in some others. It is important to examine the policies and collaborations in which the 
WHO is currently involved to assess the reasons for its success in some projects and its failures 
in others. While the WHO's detractors support its focus on disease prevention and eradication, 
many argue that success has often eluded the WHO because the organization is too bureaucratic 
and decentralized to effectively and efficiently target funds and efforts. The WHO has faced 
strong criticism for its alleged inefficiency in governance, and recent directors-general have 
pledged that improved efficiency will be a top priority. It is important to study the governance 
structure of the organization to evaluate its failures in programs and projects.  
Initiatives 
The WHO participates in a number of partnerships, programs, and alliances for global 
health development. Recently, there has been a surge in the number of global health initiatives. 
The pharmaceutical industry has played a significant role in initiating several of these 
partnerships with private foundations like the Bill and Melinda Gates Foundation. Owing to its 
international authority in public health, the WHO is, by default, an integral member in most of 
                                                 
62
 World Health Organization, "About WHO," WHO, available at http://www.who.int/about/en/. 
63
 WHO, "International Health Regulations (IHR)." 
18 
these partnerships. According to the WHO, both Global Health Initiatives (GHIs) and PPPs have 
global strategies to target specific communicable and non-communicable diseases. They pour 
substantial resources into the system in order to achieve their desired results. Such initiatives are 
thought to be one of the benefits of globalization.64 The Mectizan Donation Program (MDP) is a 
PPP created by Merck and the Task Force for Child Survival and Development (an NGO). The 
WHO has been the MDP’s integral partner since its establishment. Its commitment to the project 
has been remarkable, and the MDP has been considered one of the most successful PPPs to date. 
The Global Alliance for Vaccines and Immunization (GAVI) is another global effort that seeks 
to strengthen childhood immunization programs and bring a new generation of recently licensed 
vaccines into developing countries. These include vaccines against hepatitis B, childhood 
meningitis, yellow fever, and respiratory infections—diseases that together form the leading 
cause of death in children under age five.65 Tropical Diseases Research Programme (TDR), 
established in 1975 by the WHO, is a Special Program for Research and Training in Tropical 
Diseases. It is a global program of scientific collaboration that helps to coordinate, support, and 
influence global efforts to combat major diseases among the poor and disadvantaged. It is co-
sponsored by the United Nations Children's Fund (UNICEF), the United Nations Development 
Program (UNDP), and the World Bank. The Smallpox Eradication Program, launched in 1966 by 
the WHO, historically remains one of the great achievements of the WHO. In 1980, the 33rd 
World Health Assembly endorsed the conclusions of the Global Commission for Certification of 
Smallpox Eradication that smallpox had been eradicated worldwide and that the return of the 
virus was unlikely. Initiatives like the Malaria Eradication Program by the WHO and the “3 by 
5" initiative, launched by the UNAIDS and the WHO, have both been declared failures. This 
thesis discusses these initiatives in detail in subsequent chapters. 
This thesis seeks to gather information by employing institutional history to delve further 
into the structure of old international health organizations, looking at predecessors of the WHO 
and then eventually the WHO itself.  An institutional history draws out and synthesizes lessons 
that may prove useful for research organizations and partners, as well as for others in similar 
                                                 
64
 World Health Organization, "Global Health Initiatives," WHO, available at 
http://www.who.int/trade/glossary/story040/en/index.html. 2008 
65
 Ibid. 
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circumstances.66 The thesis also looks to compare the complex governance structures of the 
World Health Organization over decades. Different perspectives on the evolution and adaptation 
of the three elements of governance over time will be analyzed. For this purpose, the thesis will 
feature information from resources such as literature reviews (journal articles, database searches, 
books), personal interviews, seminars, conferences, videos, and audiofiles (podcasts).67 The 
thesis is structured according to the following overall research approach:  
Chapter 2 reviews the concept of governance by discussing the concept of global 
governance. This chapter also lists the different definitions and explanations of governance put 
forth by various international organizations and experts.68 The chapter then goes on to explain 
the significance of governance in global health based on the Ackleson-Lapid definition from 
which the three essential elements of governance are distilled. The second half of the chapter 
analyses the shift in governance structures in international public health over time. It provides an 
overview of PPPs, focuses on some important partnerships in the current global health scenario, 
and concludes by reiterating the importance of incorporating the three elements into any health 
initiative.  
Chapter 3 summarizes the history of international cooperation in international health and 
the predecessors of the WHO. The second half of the chapter explains the process of the creation 
of the WHO, identifies and tracks the evolution of its governance structure over decades, 
searches for the three elements of governance in the organization, and studies their 
implementation over time. The chapter cites the reasons for the creation of an international 
health organization like the WHO and highlights some landmarks achieved by the organization 
over the past sixty years. 
Chapter 4 illustrates selected initiatives where the WHO has been an integral partner. The 
chapter discusses successful projects like the Mectizan Donation Program, GAVI, and TDR, as 
well as ineffective ventures like the Malaria Eradication Program, and the “3 by 5” AIDS 
                                                 
66
 Shambu Prasad, Laxmi T, and Wani SP, "Institutional Learning and Change A Case Study of the Tata-Icrisat 
Project," (Andhra Pradesh, India: Institutional Learning and Change (ILAC) Initiative., 2006). Distinct case studies 
offer a broad understanding of the requirements for the making of a promising organization. 
67
 The interviews have been designed to confirm or further explain the information that the author gathered from the 
literature review of these issues. 
68
 The thesis will have the definition of governance put forth by Ackleson-Lapid as the primary reference for 
analysis and comparisons. The three elements include engaging in formal informal policy actions, building public-
private partnerships, and having collaborations at multiple levels (local, national, and international). The thesis 
stresses on the observation that for efficient functioning of any health system or venture, implementation of the three 
elements of governance is essential.  
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initiative.69 It compares the governance frameworks reflected in each of these initiatives and then 
proceeds to postulate reasons for each initiative’s success and/or failure. The data will be 
compiled from discoveries made through readings, interviews, database searches, podcasts, 
conferences, and seminars. 
Chapter 5 returns to the two primary research questions and reviews the reasons for the 
incorporation of a new governance structure in the WHO. To address the questions, this thesis 
explores the conditions under which multilateral organizations and non-state actors would 
cooperate, and states would support this public-private cooperation. It is followed by a 
discussion of the degree to which the execution of the elements of governance has determined 
the success or failure of the organization and WHO’s selected initiatives. Based on a review of 
the WHO and its selected initiatives, this chapter offers suggestions for mapping the future of 
international health security. This chapter does so by endorsing the three elements of 
governance. 
 
                                                 
69
 Taking examples of contradicting outcomes is a valuable analytical method. It would be interesting to examine the 
different approaches of the WHO towards these projects. One observation to be noted is that WHO has a list of 
conditions and considerations for PPPs to be recognized as an opportunity for the WHO. 
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Chapter 2 - The Concept of Governance 
 Making sense of global governance 
Governance is not synonymous with government. Although both terms refer to goal- 
oriented activities, the term “government” suggests activities that are backed by formal authority, 
whereas “governance” refers to activities that are backed by the shared goals of a number of 
entities. These goals may or may not derive from formally prescribed responsibilities and do not 
necessarily rely on police-based powers to overcome defiance and attain compliance.70 
Historically, there has been much confusion surrounding the concept of governance. Many 
academicians and experts in the field of international relations refer to governance as a complex 
structure involving both the public and the private sectors, while some popular writers associate 
it synonymously with government.71 The objectives of governance are the same as those of 
government; the difference between the two lies in the process of reaching those objectives.72
Globalization has caused a divergence in practices of governance, resulting in a 
convergence of state institutions and non-state policies. The concept of governance covers 
extensive ground, making it critical for addressing the complex issues of a globalized world, in 
which sovereign nation states regularly face the challenge of responding to the problems beyond 
their own borders.73 There is now a need for closer global governance; hence, it is important to 
go beyond the Westphalian System of governance (derived from the term “Peace of 
Westphalia”).74 In the Westphalian System, the national interests and goals of states (and, later 
nation states) were widely assumed to go beyond those of any citizen or any ruler. States became 
the primary institutional agents in an interstate system of relations.75,76 Influence of outside actors 
                                                 
70
 James N. Rosenau, "Governance in the Twenty-First Century," Global Governance 1, no. 1 (1995). 
71
 Thomas G. Weiss, "Governance, Good Governance and Global Governance: Conceptual and Actual Challenges," 
Third World Quarterly 21, no. 5 (2000). 
72
 Kent Buse, Wolfgang Hein, and Nick  Drager, Making Sense of Global Health Governance: A Policy Perspective 
(Hampshire, England: Palgrave Macmillan, 2009). 
73
 Novotny, "Global Governance and Public Health Security in the 21st Century." 
74
 Yale Avalon Project and Yale Law School, "Treaty of Westphalia: Peace Treaty between the Holy Roman 
Emperor and the King of France and Their Respective Allies," Lillian Goldman Law Library, available at 
http://avalon.law.yale.edu/17th_century/westphal.asp. The term Peace of Westphalia denotes a series of peace 
treaties signed between May and October of 1648 in Osnabruck and Munster. The treaties, based on the concept of 
sovereign states initiated a new political order in Europe.  
75
 M. Gabel, Global Inc: An Atlas of the Multinational Corporation (New York: New York Press, 2003). 
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was not recognized. The sovereignty and equality of nation, is the linchpin of the international 
system within which the UN, and hence WHO, operate. In the Westphalian System, the WHO 
was both the “organizational platform” for nation-states as norm carriers. The classical example 
of a Westphalian structure in international health is the International Health Regulations (IHR), 
adopted by the WHO in 1969 from the international sanitary conventions in force at that time. 
The objectives of the IHR are pure Westphalian doctrine: to ensure the maximum security 
against the international spread of disease with minimal interference with world traffic. At the 
heart of the IHR is a surveillance activity that requires notification of the international 
community through the WHO.77 Since the late 1980s, health governance strategies began to 
deviate from the traditional Westphalian system. In the post-Westphalian System, the WHO has 
become more important due to the increased international and also, within the WHO, non-state 
actors have more informal influence.78 Multiple player involvement in international health stems 
from the private sector’s desire to be a part of the global regulatory and decision-making 
framework. It is also notable that the actions of one sector have an impact on the other sectors.79 
This thesis proposes that innovation in governance via the proliferation of different players may 
help to create a sustainable, win-win situation for all the parties concerned.  
Governance has undergone refinement and transformation over time. Recently, global 
governance has become a popular buzzword within communities of international relations and 
the broader social sciences.80,81 Global governance acknowledges the diversity of decision-
making styles (political and social), and it grants equal importance to nongovernmental 
organizations (NGOs), transnational networks, and scientific professionals.82 It is important to 
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 Academicians and policy experts visualize the current globalized world as an “interdependent global village,” 
within which pathogens and diseases transcend the fading national boundaries threatening populations in far off 
distances. Thus, it is important to look beyond the Westphalian system of governance.  
77
 Patrick Wallis, "SARS, Governance and the Globalization of Disease," Social History of Medicine 18, no. 3 
(2005). 
78
 Wolfgang Hein and Lars Kohlmorgen, "Transnational Norm-Building in Global Health: The Important Role of 
Non-State Actors in Post-Westphalian Politics," in Sixth Pan-European Conference on International Relations 
(Turin: GIGA, 2007). 
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 Buse and Walt, "Global Public-Private Partnerships: Part I-A New Development in Health?." 
80
 Klaus Dingwerth and Philipp Pattberg, "Global Governance as a Perspective on World Politics," Global 
Governance 12(2006). Page: 185 
81
 One of the seminars at the Global Health Council’s annual conference in Washington D.C., in June 2010 had 
Hedayatullah Saleh, an analyst and specialist in governance from Management Sciences for Health (non-profit 
group), speak about the importance of governance in health systems strengthening. She works in developing health 
systems in war hit nations like Afghanistan. Saleh voiced the exact sentiments of authors Dingwerth and Pattberg.  
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 Weiss, "Governance, Good Governance and Global Governance: Conceptual and Actual Challenges."page: 191 
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clarify that the term “global governance” takes into account not only the formal institutions and 
organizations through which the management of international affairs is often sustained, but also 
includes a wide (and seemingly ever-growing) range of actors in every domain.83 New 
governance structures have emerged over time as a result of people’s efforts to work around 
undesirable characteristics such as unrepresentative, bureaucratic governments, and inefficient 
non-market systems, which were prevalent in the 1960s and 1970s.84,85 In the late 1980s, the 
field of international development made a dramatic shift toward programs that supported 
flexibility and the fundamental realignment of economies in developing countries. This resulted 
in a reduction of the state’s role, removal of government subsidies, the privatization of state 
businesses, the liberalization of pricing, and the opening of borders to the flow of international 
trade and finance. The state was no longer regarded as the provider of economic and social 
development, but rather as a partner, catalyst, and facilitator of that objective. The improvement 
in relationships among economic, political, and social actors is also due to a revolution in 
technology, communication, and networking. This has simplified the process of transnational 
governance for market actors, NGOs, private companies, religious groups, and, in some cases, 
even criminal groups.86 
 Definition of governance 
Global governance provides a nexus of rule-making, political coordination, and problem 
solving that transcends boundaries.87 The current international focus is on the evolving system of 
political coordination (formal and informal) across multiple levels, from local to global. Public 
authorities and private players are working together to resolve problems collectively. The public 
sector here refers to national, provincial/state and district governments; local government 
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institutions and inter-governmental agencies. The term private sector denotes two sets of 
structures: the for-profit private sector encompassing commercial enterprises of any size and the 
non-profit private sector referring to NGOs, philanthropies, and other not-for-profits.88 From the 
setting of technical standards to the organization of humanitarian efforts and distribution of aid 
via NGOs, private for-profit companies and actors have become highly influential in the 
formulation and implementation of global public policy.89 Effective governance often involves 
international cooperation. Government networks are at the heart of international relations 
because they have the capacity to influence policy outcomes. Robert Keohane and Joseph Nye 
first discussed this concept and defined different modes of international cooperation. They 
suggested that intergovernmental networks (IGNs) represent diplomatic interactions that occurr 
among sovereign states led by the chiefs of governments, while transgovernmental networks 
(TGNs) occur among sub-state level officials (rather than the heads), and transnational networks 
(TNNs) occur amongst private actors like non-governmental organizations, businesses, and 
banks. These actors were involved in informal treaties, which are referred to as “soft law.”90  
Governance is the continuous process by which multiple political, economic, and social 
actors coordinate to formulate formal and informal policy actions and forge PPPs. These actions 
occur on multiple levels (e.g., international, national, regional, and local) and stretch beyond the 
parameters of traditional government. Government alone cannot solve current global health 
security problems in an era of heavy cross-border movement of people and food. The following 
definition, articulated by Drs. Jason Ackleson and Yosef Lapid, best describes the complex 
structure of governance:  
“Policy actions which are the result of a process which involves both 
formal and informal actions, coordination, and management by different 
political, economic, and social actors – in addition to governments. These 
actions occur on multiple levels, such as the international, national, 
regional, and local.” 91 
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According to the definition, governance encompasses regulations and norms that have the 
potential to address international problems. This problem-solving ability is distributed among 
various actors, including state authorities, intergovernmental organizations, non-governmental 
organizations, private sector entities, other civil society actors, and individuals in the general 
public.92 Both national and international initiatives have emphasized governance reform. Each 
movement for reform has established a set of criterion for good governance, and most are based 
on the needs and agendas of their formulators. Many different international agencies have 
created their own definitions of good governance. According to the definition of the United 
Nations, governance should exhibit the following characteristics: consensus oriented, rule 
abiding, participatory, responsive, efficient, and equitable.93 In 1996, the International Monetary 
Fund declared that "promoting good governance in all its aspects, including by ensuring the rule 
of law, improving the efficiency and accountability of the public sector, and tackling corruption, 
are essential elements of a framework within which economies can prosper."94 The IMF 
proposes that ineffective governance causes corruption within national economies. The United 
Nations Development Program (UNDP) defines governance as the exercise of political, 
economic, and administrative authority to manage a nation's affairs. It is the collection of 
complex mechanisms, processes, and institutions through which citizens and groups articulate 
their interests, exercise their legal rights and obligations, and mediate their differences. As 
mentioned earlier, it is a tedious task to arrive at a single universal definition for governance. The 
way the concept has been interpreted varies substantially among various international 
organizations and experts. 
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Table 3. List of definitions of governance from experts and international organizations 
Source  Definition 
UNDP Governance is viewed as exercise of economic, political, and administrative 
authority to manage a country's affairs at all levels. It comprises mechanisms, 
processes, and institutions through which citizens and groups articulate their 
interests, exercise their legal rights, meet their obligations, and mediate their 
differences.95 
World Bank  Governance is defined as the manner in which power is exercised in the 
management of a country's economic and social resources.96 
USAID  Governance is defined as the ability of government to develop an efficient, 
effective and accountable public management process that is open to citizen 
participation and that strengthens rather than weakens a democratic system of 
government.97 
OECD 
 
Governance denotes the use of political authority and exercise of control in a 
society in relation to the management of its resources for social and economic 
development.98 
Institute of 
Governance, Ottawa 
Governance comprises the institutions, processes, and conventions in a society 
which determine how power is exercised, how important decisions affecting 
society are made and how consensus is reached on various interests.99 
International Institute 
of Administrative 
Sciences 
Governance refers to the process whereby elements in society wield power and 
authority, and influence and enact policies and decisions concerning public life, 
and economic and social development. It involves interaction between these 
formal institutions and those of civil society.100 
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IMF Governance encompasses purposes limited to economic aspects of governance in 
improving the management of public resources, supporting the development and 
maintenance of a transparent and stable economic and regulatory environment 
conducive to private sector activities.101 
James Rosenau Governance concerns the manner through which a society or organization 
“steers” itself to achieve common goals.102 
Ackleson-Lapid Policy actions which are the result of a process which involves both formal and 
informal actions, coordination, and management by different political, economic, 
and social actors – in addition to governments. These actions occur on multiple 
levels, such as the international, national, regional, and local. 103 
 Shift in governance structures in global public health 
The world is witnessing “a remarkable expansion of collective power” that is highly 
disaggregated and unevenly spread, but still brings innovation.104 Several factors have 
encouraged this global shift in governance. The end of the Cold War was one of the main 
contributory factors to this phenomenon. After the Cold-War period, the deadlock that existed in 
the UN and its associated agencies began to dissolve.105 The resolution of conflicts between 
states, as well as reconstruction and development, topped the UN priority list following the war. 
What emerged, therefore, was a system of interstate organizations dedicated to resolving 
conflicts and supporting development collaboration.106 Globalization led to increased demand for 
multilateralism, transnational cooperation, financial stability, and standard setting in 
internationally relevant sectors. With the absence of an ultimate authority and the presence of 
fragmented distribution of authority, there was new found flexibility, as well as room for 
innovation and experimentation, in the process of development and the application of control 
mechanisms in the health sector.107 There has been a noticeable power shift in global health, 
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increasing the influence of non-state actors in many departments, especially in that of global 
policy-making. The emergence of public-private partnerships for health (PPPH) is the result of a 
range of complex factors: advances in science and technology, growth in the pharmaceutical 
industry, changes in the global framework of health governance, and the multilateral system. The 
concept of governance has evolved over time and adapted to the changing global scenario. See 
table 4 for details.  
Table 4. Historical evolution of the concept of governance 
Year  Concept of governance  
Pre-1970s • authority on a national level 
• system limited to inter-state relationships and 
exclusion of new powers/actors  
• focus on government, public service as the motor 
for economic and social development 
1980s • emergence of new powers like the IGOs, NGOs 
• focus on development and management, free-
market reforms 
• measures aimed at reducing both budget and trade 
deficits 
• incorporation of state leadership in development 
process 
1990s • expansion to include civil society, and private 
players 
• emphasis on democratic processes and values 
• privatizing of state businesses, and opening of 
borders to the flow of international trade and 
finance 
• multilateral approach to economic and social 
development and efforts to combat threats to 
peace, health, and security 
Source: Adapted from "Developing Capacity for Effective Governance." UNDP, available at www.undp.org. 
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Prior to the late 1970s, partnership between the private and public sectors were virtually 
non-existent did not exist within the UN or any other international development organization.108 
The few discrete partnerships involved donor agencies and recipient country governments. In the 
late 1960s and early 1970s, flaws began to appear in the economic growth theories of various 
developing countries, and it became increasingly evident that modernization efforts were failing 
to tackle the poverty that was so obviously leading to various global health issues. By the early 
1980s, influential international organizations acknowledged and campaigned for a greater role 
for the private sector. Donors started to look beyond their original roles and began to form 
broader relationships, taking up new responsibilities.109 Some experts have chosen to arrange the 
history of global health governance over three periods: the 1970s to mid-1980s, the mid-1980s to 
1990s, and the mid-1990s to 2000s. The first period is characterized as the era of primary 
healthcare, the second period as that of health reforms, and the third period as the era of global 
partnerships.110,111 The 1970s was the era of biotechnological revolution. Newly produced 
vaccines produced had great potential to improve the immunization status in the Third World. 
However, public funding went only to basic research and only private companies invested in the 
development of high-quality, novel, and expensive vaccines and products. Thus, in order to gain 
high returns, these companies limited their focus to the developed market and did little to resolve 
the issues of public health in the developing world. During the 1990s, industry began to 
recognize the potential benefits of alliances with the UN and other intergovernmental groupings. 
Industry embarked upon a strategy to gain access to and influence the multilateral decision-
making process. One major outcome of the industry effort is a joint statement by the UN and the 
ICC (International Chamber of Commerce) in 1998. It proposed that “broad political and 
economic changes have opened up new opportunities for dialogue and cooperation between the 
UN and the private sector.” The focus areas included establishing an effective regulatory 
framework for globalization and raising the productive potential of poor countries by promoting 
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private-sector involvement.112 The creation of PPPs is also attributed to the disease burden in the 
developing world, especially in the late 1980s. The HIV/AIDS epidemic was a major 
contributing factor, as was the reemergence of diseases such as tuberculosis and chloroquinone-
resistant malaria. By the early 1990s, many manufacturers had stopped producing the less 
profitable vaccines (ones used in the Third World), preferring to focus on meeting wealthier 
nations’ demands for the newer and more expensive ones. This product divergence affected both 
availability and price of the medicines and vaccines. Thus, partnerships were required to modify 
their market strategies and make deals with the private sector.113  
Realizing the gravity of the situation, Gro Harlem Brundlandt, former Director-General 
of the WHO, made one of the most relevant comments of the 1990s pertaining to the global 
health scenario: 
“…Partnership is what is needed in today’s world, between government 
and industry, producers and consumers, between the present and the future. 
We need to build new coalitions…We must agree on a global agenda for the 
management of change…We must continue to move from confrontation, 
through dialogue to cooperation…Collective management of the global 
interdependence...is the only acceptable formula in the world of the 
1990s.”114  
 Significance of governance in global public health 
Health governance involves the actions and means by which an organization or society 
promotes the protection of a population’s health.115 This organization may be formal or informal, 
and the mechanisms it uses may occur at local, regional, national, and international levels, 
involving public or private sectors (or a combination of both).116 Disease among the world’s 
poorest people is an enduring reality and the profound disparities in health and life expectancy 
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between the rich and the poor are resistant to change.117 Health system governance concerns the 
actions and means adopted by a society to organize itself in the promotion and protection of its 
population’s health.118 Conveniently, health can be considered to be both a source and a product 
of economic development; however, this fact puts both governmental and nongovernmental 
actors in the position of having to actively participate in public health initiatives.119 This value of 
investing in public health has gained momentum, and it is now considered to be a core criterion 
of “good governance.”120  
The last decade has witnessed increased efforts to tackle the developing world’s diseases. 
Indeed, it has become a key feature in the foreign policy stances of many nations. The reasons 
for this shift are numerous. Some regard this newfound focus as the moral duty or a 
philanthropic responsibility of the developed world; essentially, to whom much has been given, 
much is required. Others regard the shift as a selfish investment on the part of developed 
countries to indirectly protect their own citizens from disease threats (since microbes do not 
respect borders).121 More and more people from diverse backgrounds—even celebrities and high 
ranking political figures—are pouring money and resources into global health improvement, not 
only for philanthropic reasons, but also for political gain. The conspicuous voids left by the 
traditional governance system in the face of global health crises have prompted the creation of 
various initiatives; some of these are sponsored multilaterally, while others are sponsored by 
non-state actors such as nongovernmental organizations (e.g., humanitarian organizations, 
industry associations, foundations and other private associations) and businesses (e.g., 
pharmaceutical companies). In some cases, states and intergovernmental organizations are 
attempting to address global health problems by joining forces with non-state actors to form 
public-private partnerships (PPPs or “hybrid” organizations). Examples of such partnerships 
include the Global Fund for HIV/AIDS, tuberculosis and malaria (also known as “The Global 
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Fund”)122, the International Finance Facility for Immunization, and other organizations.123 
Taking into consideration the health challenges that the world continues to confront, impressive 
innovation in governance has come about through international response to these problems. One 
such innovation is the widespread development of PPPs. 
Polycentric distribution is a primary characteristic of contemporary global health 
governance. Today’s global health governance structure is confronted with six “grand 
challenges” that are vital to the improvement of world health and the reduction of health 
disparities. These challenges include:124  
1. the need for collaboration and coordination of multiple players;  
2. the lack of global health leadership; 
3. the need to harness creativity, energy and resources for global health; 
4. the neglect of basic survival needs;  
5. the lack of funding and priority setting; and  
6. the need for accountability, transparency, monitoring, and enforcement of 
health regulations and standards. 
It is important to note that all of these challenges are interconnected and, in some instances, 
overlapping. Thus, a focused and well-rounded approach is necessary to appropriately and 
adequately address these issues as part of today’s global health agenda.125 The definition of 
governance forth by Ackleson-Lapid will probably offer effective solutions to these 
challenges.126 One of the essentials for resourceful governance is believed to be the building of 
and working through PPPs or GPPPs.127 PPPs, which were formalized in the early to mid-1990s 
as a central feature of international health, have been portrayed as an opportunity to expand 
funding and improve efficiency in international health efforts. This has allowed PPPs to 
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influence the public health agenda and lend legitimacy to corporations’ activities through 
association with UN agencies. The World Bank is now the largest multinational development 
agency, providing an average of US $2 billion per year for health programs. Many private for-
profit organizations have come to recognize the importance of public health goals for their 
immediate and long-term objectives, and they have come to accept a broader view of social 
responsibility as a part of their corporate mandate. Many pharmaceutical companies are now 
involved in a number of drug donation programs based on partnerships with the WHO, UNDP, 
and other organizations.128  
A good working definition for PPPs includes three points. First, these partnerships 
involve at least one private for-profit organization and at least one not-for-profit organization. 
Second, the core partners have joint shares in both the efforts and rewards. Finally, partnerships 
in public health are committed to the sustained maintenance of social value (improved health), 
especially for disadvantaged populations.129 The portfolio of UNFIP, which is broadly 
representative of the UN-supported public-private initiatives, indicates that roughly 43% of 
UNFIP funding was allocated for health programs, about 25% for environmental partnerships, 
and 21% for women’s rights and population partnerships.130 A GPPP for health is defined as a 
collaborative relationship that transcends national boundaries and brings together at least three 
parties, including a corporation (and/or industry association), an intergovernmental organization, 
and civil society.131 Together, these parties work to achieve a shared health-creating goal on the 
basis of a mutually agreed division of labor. Thus, it can be said that it is imperative to embrace 
PPPs. While collaborating, the main point to be emphasized is the “win-win” outcome for both 
parties. For multilateral organizations and federal authorities, partnership with the private sector 
seems to;132   
1. bestow more business credibility and authority,  
2. extend increased resources available, and 
3. facilitate access to private sector skills and management talents.  
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For private entities, a partnership with non-state players offers the following:133   
1. increased corporate influence in global policy-making,  
2. improved overall financial benefits through brand and image promotion, and  
3. enhanced corporate authority and legitimacy through association with the UN and other 
reputable international bodies.   
Transnational partnerships usually involve larger partnerships and complex groupings; 
depending upon their structure, they may bring together several governments, local and 
international NGOs, research institutions, and even UN agencies. Such partnerships can be 
coordinated by different entities. PPPs pool public and private resources, and capitalize on the 
skills of the respective sectors to improve the delivery of services. The WHO is the initiator of 
most of these partnerships, and it engages private commercial sector participants such as in the 
case of Global Alliance for Vaccines and Immunization (GAVI), Roll Back Malaria (RBM), 
Stop TB partnership (Stop TB), Safe Injections Global Network (SIGN), Global Polio 
Eradication Program (PEI), the Special Program for Research and Training in Tropical Diseases 
(TDR), and the Special Program for Research Development and Research Training in Human 
Reproduction (HRP), among others. Partnerships can be primarily company-owned such as in 
the case of Action TB and can be legally independent as evidenced by groups such as the 
International Aids Vaccine Initiative (IAVI), Medicines for Malaria Venture (MMV), the Global 
Alliance for TB Drug Development (GATBDD), the Concept Foundation (CF), and the Mectizan 
Donation Program (MDP). The Malaria Vaccine Initiative (MVI) and the HIV Vaccine Initiative 
(HVI) are a few examples of civil society-initiated partnerships.134 Global health partnerships 
(GHPs) have made impressive contributions to international health. These contributions have 
been particularly commendable in the areas of drug delivery, research and development, and 
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policy-making. In the area of research and development, they have resulted in the invention of 
new drugs like CoArtem and Lapdap (for malaria), and Impavido (for leishmaniasis). The 
product access that GHPs such as MDP, Stop TB, and GAVI have to these drugs has proven to 
be a remarkably effective tool for supplying quality drugs at a reduced cost, as well as for 
introducing antiretrovirals in many poor countries. One of the main highlights of such a 
partnership has been the renewed public attention to health issues and the resulting bank of 
resources being generated to combat communicable diseases. Hence, it is important to 
acknowledge the emerging global reality characterized by a tripartite relationship among 
government, nonprofit groups, and the private sector. However, only win-win or mutually 
beneficial strategies will receive the funding, leadership, and attention necessary for success.135 
Partnerships are a type of business model that help in reaching the “bottom of the 
pyramid,” providing goods and services to the poorest people in the world. 136 One example of 
this type of model can be seen in India’s state of Uttar Pradesh, where USAID funded a POUZN 
(Point-Of-Use Water Disinfection and Zinc Treatment) operation called Jal Mitra (friends of 
water). The underprivileged vulnerable population was targeted and educated to use disinfected 
(POU) water.137,138 The state government, local NGOs (whom the community trusted), and 
private companies worked together to distribute the sustainable POU devices. C.K. Prahalad, 
professor at the Stephen M. Ross School of Business in the University of Michigan, proposed 
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that national governments and businesses should stop looking at these poor segments of the 
population as victims, but rather as consumers. Entrepreneurial solutions such as these place a 
minimal financial burden on developing countries. Incorporating multiple levels of cooperation 
in local, national, and international arenas is another important aspect to be addressed. The 
essential point is that global health problems require global solutions, and neither public nor 
private organizations can solve these issues on their own.139 Embracing this transformed 
governance structure helps to produce innovative and powerful mechanisms for addressing 
daunting challenges through the leveraging of ideas, expertise, skills, and resources from 
different partners.140   
 Conclusion 
Globalization has forced the international community to recognize that the forces 
currently shaping the world are not necessarily restricted to the traditional apparatus of the state; 
they also encompass international organizations, institutions, private entities, and civil society 
groups outside of the state. The problems of development are complex, and the search for 
solutions is a continuing effort on the part of national governments and non-governmental actors 
alike. The concept of governance has evolved over the last 50 years due to the different theories 
and ideas that have played a role in configuring the contemporary world.141 The change in 
governance structures over time can be attributed to the lack of efficiency on the part of the 
public sector and international organizations. Since the 1970s, important changes have taken 
place in international health governance. Technological advances, the rise of new and re-
emerging diseases, and a lack of public funding are some of the factors that have necessitated 
involvement of non-state actors in the global health system. The current global governance 
structure has proven to be a way of successfully building and engaging multi-layered 
perspectives and networks. Inadequate funding and the complicated nature of bureaucracy have 
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limited the abilities of many national governments and international institutions to provide good 
public health services—a reality that has contributed to the contemporary form of governance. 
This shift to other forms of governance like partnerships, coalitions, and informal collaborations 
can be further analyzed through a study of a multilateral health organization like the WHO, 
which will be accomplished in the next chapter.142 PPPs assist the government financially and 
provide human resources. Private sector businesses are lured into these partnerships by public 
sector offerings of subsidies or incentives. Such partnerships also help in the production and 
distribution of health-related products to every possible corner of the world. The Ackleson-Lapid 
definition of governance proposes sharing of decision-making and responsibilities of health 
among governments, multilateral institutions, civil society, and the private sector.143 Both the 
public and private sectors have unique roles to play in addressing and overcoming the challenges 
of maintaining and sustaining effective international health systems.  The three essential 
elements put forth by Ackleson and Lapid can be effective instruments for strengthening these 
health systems. 
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Chapter 3 - History of international cooperation in public health 
and the role of governance 
 The pre-WHO era 
The influenza pandemic of 412 BC, the plague of Athens in 430 BC, the Black Death in 
the 14th century, and the transatlantic exchange of infectious diseases following Columbus’ 
contact with the new world in 1492 were all historically significant events that presented major 
challenges to the prevention and control of disease spread across continents.144 By the 18th 
century, epidemics were more isolated and scattered. Many technologies, such as steam power 
and railways that arose during the Industrial Revolution in the 19th century, made international 
travel an accessible reality. During the same period, waves of communicable diseases swept 
across Europe. The European imperialism in the 19th century, joined by similar expansion 
efforts on the part of the US and Japan, led to large-scale movement of people and capital. This 
also led to nations becoming more integrated.  This integration, which came about as a result of 
quicker and easier travel, was characterized by a swell in international trade and the 
unprecedented widespread mingling of different populations.145 The 1918 influenza pandemic 
disrupted trade and public health to a large extent, killing approximately 25 million people 
worldwide. Public health cooperation only a little later in the 19th century. It was initiated by the 
creation of international health institutions in 1838 and was followed by a succession of 
International Sanitary Conferences from 1851 up to the eventual drafting of sanitary 
conventions.146  
The increased speed and movement via transportation was a stimulus for international 
trade, but it also resulted in rapid and extensive spread of epidemics like cholera. The Industrial 
Revolution also resulted in crowded living conditions which were a breeding ground for 
diseases. These factors caused state officials and physicians to begin contemplating how cross-
border cooperation could benefit the security of health. With greater interconnectivity, an 
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individual country’s health issues posed a real threat to the health of other countries’ populations. 
The European nations were wise to begin considering the benefits of cross-border cooperation in 
the realm of health security, because lack of global public health security can impact a nation’s 
political stability, trade, tourism, and access to goods and services. There were outbreaks of 
cholera in London in 1831, 1848-49, and in 1866.147 In 1832, the cholera pandemic caused 
21,000 deaths in Paris alone, just 7 months after the disease had arrived from England.  It was 
through cholera epidemics that epidemiologists finally discovered the link between sanitation 
and public health, a discovery that provided the impetus for water and sewage system 
improvements. Over the first half of the 18th century, progress in international public health was 
limited to minimizing hindrances to trade and transport, as well as developing Europe’s public 
health defense mechanisms for preventing the spread of cholera. The book Airs, Waters, and 
Places, written in the 5th or 4th century BC, by Hippocrates, shows the first evidence of a 
systematic attempt to establish the existence of a causal relationship between human diseases and 
the environment.148 The 19th century featured the creation of four regional health institutions to 
regulate implementation of quarantine measures in the Mediterranean region: Conseil Superieur 
de la sante de Constantinople (1839), Counseil sanitare, maritime et quarantenaire d’Alexandrie 
(1843), Conseil sanitaire de Tanger (1840), and that of Tehran (1867).149 However, the first 
International Sanitary Conference (ISC), attended by the 12 governments, was not held until 23 
July 1851.150  
Between 1851 and 1938, fourteen International Sanitary Conferences were held, laying 
the foundation for broader international cooperation. The ISCs are a historical example of the 
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presence of trans-governmental networks in the realm of public health security. The 
representatives who attended the conferences included not only the chiefs of government, but 
also lower-level officials, physicians, and sanitary authorities. These delegates were then 
responsible to report the decisions made at the conferences to their governments for 
implementation. There were no treaties or formal agreements signed at the ISC; their 
functionality relied on governments’ cooperation by adopting the policies discussed.151 Thus, the 
need for transnational governance and involvement of professionals from all fields of expertise 
was noted. A draft convention was signed in 1852 concerning plague, yellow fever, and cholera. 
In 1892, the ISC agreed to set out quarantine and hygiene practices. It defined quarantine 
regulations for all ships coming into Mediterranean through the Suez Canal. The 7th conference 
at Dresden (held in 1893) required all signatory states to notify one another of any outbreak of 
cholera within their boundaries. This move reduced inland quarantine measures between states. 
The third and fourth conventions, signed in 1884 and 1887 respectively, dealt with plague 
quarantine regulations for those on pilgrimages to Mecca.152 The four Sanitary Conventions were 
agreed upon by 1903, and were later codified and formatted into the International Sanitary 
Regulations, the forerunner of the current International Health Regulations.153 The highlight of 
the 1903 convention was the discussion of the three major epidemic diseases of the time—
cholera, plague, and yellow fever. This conference was a landmark in the field of scientific study 
of epidemic diseases.  
The 5th ISC (held in 1881) in Washington had recommended the adoption of a draft 
convention to create an international agency dealing with health questions on a regular basis. The 
agency would also aid in promoting studies on epidemics and help with the implementation of 
quarantine measures and the periodic holding of ISCs. The 1902 meeting of delegates of the 
sanitary conferences created the Pan American Sanitary Bureau (PASB). The functions of the 
PASB included the exchange of epidemiological information, the dissemination of data on 
health, the provision of assistance in fighting epidemics, and the improvement of sanitation of 
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harbors and cities.154 The French government proposed an international health office. This 
proposal was favorably received, and on 9 December 1907, a permanent body, the Paris-based 
Office International d’Hygiene Publique (OIHP) was created to collect and report 
epidemiological data from its member states.155 The office helped to disseminate information on 
communicable diseases and information that would be of general public health interest. During 
the World War I, the OIHP reduced its activities, but continued to publish a bulletin. The bulletin 
dealt mainly with war-related problems such as infected wounds, gangrene, cutaneous parasites, 
and tetanus. Early in 1920, a plan for a permanent international health organization was approved 
by the League of Nations. The OIHP, however, was unable to participate in an interim combined 
League-OIHP committee. This was partly because the US, which was not a member of the 
League, wished to remain in the OIHP but could not if the OIHP were absorbed into a League-
connected agency. The OIHP existed for another generation, maintaining a formal relationship 
with the League of Nations. The next major development was the creation of League of Nations 
Health Organization (LNHO) in 1923, which was part of the parent organization, the League of 
Nations.156 Set up in 1920 in the aftermath of the World War I, the League of Nations was 
backed by a number of prominent men and women, including the United States’ President 
Woodrow Wilson, who argued that the Treaty of Versailles—which ended World War I—should 
include provisions setting up a peace-keeping body to police international affairs. These 
provisions eventually became the Covenant of the League of Nations. However, the League's 
powers were limited. The absence of the United States weakened it from the outset.157 The 
LNHO conducted studies on rural hygiene, primary health education, biological standardization, 
nutrition, malaria, TB, leprosy, syphilis, rabies, and cancer. The conference met in New York 
and on 22 July 1946 adopted a constitution for the World Health Organization, which would 
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carry on the functions previously performed by the League and the OIHP.158 Thus, there were 
three major health organizations operating almost simultaneously in different parts of the world, 
a situation that eventually led to overlapping of ideas and inter-organizational rivalry.  
The transition in international health cooperation can be summarized over four periods:159 
1. The Industrial Revolution of the late 18th and mid 19th century, when the first 
ISCs came into existence. 
2. The period between both the World Wars, with the establishment of international 
organizations such as the PASB, the OIHP, the League of Nations (LN), and also 
the rise of private American foundations like the Rockefeller Foundation and the 
Red Cross Society. 
3. The post World-War II era, highlighted by the birth of the WHO. 
4. The more recent periods starting from the 1980s, which have witnessed the 
proliferation of new players (both state and non-state) in global public health 
initiatives, in the area of disease prevention, and health policy-making. The 
involvement has been seen at all levels from domestic to national to international.   
 History and creation of the WHO 
The 20th century promised a healthier future in many ways. It witnessed advances in 
medicine, sanitation, hygiene, and public health. The WHO came into existence after World War 
II, when the victorious powers came together to create an international health organization to 
produce health for all and assist new governments in building healthier nations.160 It has been 
more than 60 years since the establishment of the WHO, and the organization is regarded as a 
landmark development in international cooperation post World War II. This thesis, written in 
response to widespread criticism of the WHO’s inefficient governance structure, reviews the 
history and creation of the organization. Considering the organization’s journey from being an 
undisputed leader in international health to an entity now trying to regain its authority, the WHO 
makes for an interesting case study in the arena of global public health. 
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When the United Nations was formed in 1945, there was a significant need for 
organizations that would take charge of globally relevant matters such as health, trade, and labor. 
In 1945, the delegates of a UN conference in San Francisco decided to establish an international 
health organization with the Economic and Social Council (ECOSOC).161 In 1946, this council 
nominated a Technical Preparatory Committee to draft proposals for the upcoming International 
Health Conference. The committee included members from PASB, LNHO, OIHP, and the 
United Nations Relief and Rehabilitation Administration (UNRRA). It recommended that OIHP 
be merged with this new organization.162 Thus, on 19 June 1946, the International Health 
Conference in New York agreed upon the new international health organization, calling it the 
World Health Organization (WHO). The conference had delegates from the 5 UN member states, 
as well as 16 non-UN member states (invited as observers), 3 Allied Control Commissions, and 
several international non-governmental organizations.163,164,165 An interim commission was set 
up to transfer powers and prepare for the first World Health Assembly (WHA). The WHO was 
founded shortly afterward and its constitution came into force on 7 April 1948, a date that is now 
annually celebrated as the “World Health Day.” Dr. Brock Chisholm was appointed as the first 
Director-General of the WHO. Within the UN, the WHO is categorized as one of the specialized 
agencies with an office located within the UN headquarters. This demonstrates the interlinked 
nature of global health with global peace.166 Since its foundation, the objective of the WHO has 
been to ensure access to health services to people around the globe that will enable them to lead 
socially and economically productive lives.  
The constitution at the outset mandated the WHO to serve as a specialized agency of the 
UN for global health matters. The WHO is composed of three main operating bodies: the World 
Health Assembly (WHA), an Executive Board of health specialists (elected for three-year terms 
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by the assembly), and a Secretariat, headed by the Director-General.167 The regional offices of 
the organization are headquartered in Alexandria (Egypt), Brazzaville (Congo), Copenhagen 
(Denmark), Manila (Philippines), New Delhi (India), and Washington, D.C. (USA). Membership 
in the organization is open to all nation states, and member countries of the UN may become 
members of the WHO by signing an agreement accepting the WHO constitution. Other countries 
may be admitted as members when their application has been approved by a simple majority 
vote of the WHA. At the first WHA, which took place on 24 June 1949, 48 members were 
present. As of 2011, there are 193 member states. The WHA, as the principal organ of the WHO, 
is composed of delegates from all member states. It determines the organization’s policies, 
approves the budget, and plays a supervisory role over the organization’s programs and projects. 
Since the WHO’s establishment, the WHA has been involved with conducting research by 
setting up its own institutions and by cooperating with both official and non-official institutions 
of member states. The first WHA gave direction to the future orientation of the organization’s 
activities.168 The WHO sets up collaborating centers designated by the Director-General to form 
part of an international collaborative network carrying out activities in support of the 
organization’s programs at all levels. The function of these centers include collection and 
dissemination of information; standardization of terminology, nomenclature, technology, and 
diagnostic procedures; research training; coordination of activities carried out several institutions 
on a given subject; and participation in collaborative research developed under the leadership of 
the WHO.169 Programs in the WHO were grouped in order of importance. Malaria, maternal and 
child health, TB, venereal diseases, environmental sanitation, and nutrition belonged to the “top 
priority class.” Second class status was given to public health administration, third to parasitic 
diseases, fourth to viral, and fifth to mental diseases.170  
One of the first challenges for the WHO after it came into force in 1948 was the 
replacement of existing quarantine and sanitary rules with the International Sanitary Regulations, 
developed in 1951. Following the addition of some new material to this 1951 agreement, it was 
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renamed the International Health Regulations (IHR) in 1969. The IHR were promulgated by the 
WHO under Article 21 of its 1951 constitution, and according to the WHO, they constituted the 
"only international health agreement on communicable diseases that is binding on the 
(WHO).”171 The member states were obliged to notify the WHO of any incidences of cholera, 
plague, or yellow fever. Health organizations were required to work in tandem with surveillance 
operations to achieve maximum security against the international spread of disease.172 The IHR 
had its set of fierce criticism, and was labeled the “toothless sleeping treaty.”173 After several 
deliberations and discussions, the agreement was revised in 2005, to make it more relevant in 
today’s global public health situation. The revised regulations seek to strengthen national health 
systems by producing more robust health governance, both horizontally (among states) and 
vertically (within the epidemic-prone diseases). The WHA’s Resolution 54.14, “Global health 
security: epidemic alert and response,” linked the health security concept to a global strategy for 
the prevention of movement of communicable diseases across national borders. This 2001 
resolution supported the revision of the IHRs. The stated purpose and scope of the IHR are "to 
prevent, protect against, control and provide a public health response to the international spread 
of disease in ways that are commensurate with and restricted to public health risks, and which 
avoid unnecessary interference with international traffic and trade."174,175 The revised regulations 
grant new powers to the WHO, including an information-gathering responsibility that is not 
limited solely to official state notifications or consultations, but covers all available scientific 
evidence and other relevant information. The WHO can consult unofficial reports and facilitated 
collaboration from the countries through verification requests. The new IHR constitute a shift 
towards an expanded governance strategy that integrates multiple threats, actors and objectives 
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in a flexible, forward-looking and universal manner.176 The approach to transnational networks, 
PPPs, and their success or failure is significantly influenced by the history and governance 
pattern of the multilateral organization (in this case, the WHO).  
 Structure of the WHO: Identification of the elements of governance 
International health governance occurs via organizations like the World Health 
Organization. The WHO has long been instrumental in monitoring and responding to disease 
outbreaks, setting standards for health reporting, and developing technical expertise for member 
countries.177 The WHO holds the main responsibility for public health at a global level. Media 
attention has been focused on auxiliary factors such as leadership of the WHO, rather than on the 
real factors that limit its effectiveness. These factors relate to the organization’s structure and 
also to its current priorities, methods, and management.178 The WHO has been criticized 
repeatedly for various reasons. It was criticized for its lack of activity in public health. The 
organization has also been labeled a failing bureaucracy. Several factors have led to the WHO 
being ineffective. The functioning of the WHO occurs through regional offices who advise their 
regions on technical matters, finance the training of health professionals, and influence health 
policy decisions. The WHO itself has no direct authority to intervene in policy-making and 
disease prevention in nations. Actions at all policy levels—district, state, national, and 
international—have a strong impact on the organizational stature. The WHO’s collaboration 
centers participate on a contractual basis in cooperative programs supported by the organization 
at the country, inter-country, regional, interregional, and global levels.179 With the ability to work 
through policies and laws, local people and workers are better able to organize themselves. The 
ambiguous nature of responsibilities has led to the misrepresentation of the WHO.180 The centers 
are a good example of collaboration at multiple levels by the WHO. It was noted that, by the 
1990s, it was poorly managed and had major structural problems. It has also been accused of 
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cronyism, and operating on a stagnant budget. The WHO guidelines and procedures are a 
hindrance to its own programs.181 The WHO and the UN agencies such as the International 
Labor Organization, Food and Agricultural Organization (FAO), United Nations Children's Fund 
(UNICEF), and the UN Population Fund have shared a global role in both regulation and 
development. Since the 1980s, however, the OECD and World Bank have also become involved 
with health sector and policy reforms.182 One factor behind the weakening of the WHO has been 
the increased influence of the World Bank, which plays a major role in health policy-making and 
the funding of developing nations. Global leadership and advocacy remain the major missing 
ingredients in the WHO’s formula in making a difference in health worldwide.  
The perception that the UN was anti-business did not arise until the end of Cold War. The 
binding codes and stringent rules that were set for all the multinational commercial enterprises 
contributed to this anti-business image. Kofi Annan’s appointment as UN Secretary-General is 
believed to be the one of the major reasons for the shift from anti-business to pro-business 
approach in the UN. The first milestone in this shift was the establishment of the United Nations 
Fund for International Partnerships (UNIP) in 1997. In many of Annan’s public addresses, he 
reiterated the need for shared values and principles. The Millennium Development Goals laid out 
by the UN have also explicitly dedicated the eighth goal to “developing a global partnership for 
development,” meaning more collaboration with private and non-state actors.183 The MDGs 
justifies the significance of incorporation of the Acklesonian-Lapidian elements of governance in 
the UN and its agencies. 
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The evolution of the WHO’s strategy and programs, when studied in relation to the 
international political climate, can be divided into the following periods:184 
1. 1948 to 1962: initial challenges, structural organization, delegation of duties, and    
responsibilities 
The year 1948 is marked by the birth of the WHO and the Cold War. In spite of the Cold 
War, there was consensus on the WHO’s authority in international health. The Soviets backed 
the WHO and provided support for WHO public health campaigns, even in the years when the 
USSR was not an active member (1949-1957). The organization, being naïve, had to combat the 
challenges of a post World War II world. The WHO was still establishing its governance 
structures and its strategies were yet to be tested. The concept of health began to be considered as 
an indispensable pre-requisite to industrial and agricultural development, as well as to social 
progress among nations that were still reeling from the effects of war. The WHO initiated many 
sanitation and disease control measures during this period. This led to increased use of 
antibiotics and insecticides, attracting pharmaceutical companies’ interest in the process. The 
cooperation between private industry and the WHO dates back to this period, although the 
relationship was more often a conflicted one.185 The 1950s also demonstrated growing concern 
of the WHO for environmental health. As evident from the global map of activities, this period 
can be characterized as the beginning of new era in health cooperation and emergency 
management.  
2. 1963 to 1972: focus on health, development, and vaccination programs 
The objectives in the 1960s were similar to those of the 1950s. Campaigns against 
communicable diseases became stronger and broader, with diseases such as TB, poliomyelitis, 
leprosy, bihharziosis, and malaria being targeted.186 In 1967, the WHO launched an intensified 
plan to eradicate smallpox; the "ancient scourge" threatened 60 percent of the world's population, 
killed every fourth victim, scarred or blinded most survivors, and eluded any form of treatment. 
This decade was one of intensive preparation and training of all UN agencies, as well as of 
programs promoting development in the recently independent nations. At the end of 1967, there 
were 126 member states, as compared with 85 in 1957. The new members came particularly 
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from parts of Africa served by the WHO's Regional Office in Brazzaville, and the number of 
member states in Africa grew from 3 in 1957 to 29 in 1967.187  
3. 1973 to present: new strategy of “Health for All by the Year 2000” with the 
involvement of non-state actors, and private enterprises 
Incorporating the attributes of institutionalization and professionalization of international 
health into the WHO were the organization’s highlights following World War II. Its most 
prominent activity was the eradication of smallpox and the formulation of the “Health for All by 
the Year 2000.” The Declaration of Alma-Ata was adopted at the International Conference on 
Primary Health Care (PHC), Almaty (formerly Alma-Ata), currently in Kazakhstan, 6-12 
September 1978. This conference convened jointly by the WHO and UNICEF made a 
declaration recognizing primary healthcare as key in attaining Health for All. In May 1981, the 
WHA adopted this global strategy of “Health for All by the Year 2000.”188,189 The 1980s was a 
decade of structural adjustment that lacked international agencies’ concern for health. By the 
1980s, there was mounting dissatisfaction, arising from different quarters, regarding the 
fulfillment of international health goals. In the 1990s, the WHO expanded and restructured its 
global policy agenda, shifting away from traditionalism in favor of a more neoliberal approach to 
decision making within the health sector.190 The gradual involvement of funding agencies, 
something that started in the beginning of the 1990s, gained momentum on account of various 
reasons. Such reasons included the WHO’s lack of ability to focus on data collection, research, 
analysis and action in relation to health systems, as well as incapability to give increased 
prominence to “vertical programs” (i.e., programs targeting specific diseases or action). The 
WHO steadily lost its share of international health resources and influence to competing actors. 
Despite the inefficient bureaucracy and funding issues of the 1980s and 1990s, the WHO tried to 
regain its authority by echoing the World Bank’s mission of “investing in health.” Thus, it was 
only in the late 1980s and into the 1990s that multiple players began to participate in the WHO’s 
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global health policy-making. The WHO has always been dependent on others for the 
achievement of its targets and goals. In the concept of “Health for all by the Year 2000,” nation 
states, international community, and local community members were identified as the main 
players. However, “Health for all in the 21st century,” endorsed by the WHO and WHA in 1998, 
identified PPPs as the WHO’s main group of policy responders.191 The focus of global 
development efforts was strongly oriented towards the role of nongovernmental organizations. In 
1976, the then Director-General of WHO, Halfdan T. Mahler, called for much greater use of 
NGOs in areas of primary health care and rural development. NGOs, which had practical 
experience in serving the underprivileged, started to play a major role as delivery agents for aid 
and players in policy development; they not only offered a technical skill set, but were also 
uniquely equipped to win the trust of the people.  To help the organization improve links with 
funding agencies and NGOs, WHO was urged to prepare its program of work in such a way that 
it clearly stated its priorities and important fields of endeavor, to encourage various organizations 
to allocate money for causes that the WHO considered important.192 These factors, when 
practically applied to WHO policy and action, helped to significantly enhance the impact of 
WHO resources. The NGOs informally began to help promote the cooperation and execution of 
the WHO’s activities at multiple levels. This was complemented by increased contributions from 
corporate actors such as the Gates family (via the Bill and Melinda Gates Foundation).193 The 
foundation started participating in and advocating the idea of PPPs through Roll Back Malaria, 
Stop TB, and the GAVI alliance.194 This shift in focus to include a diverse set of players was also 
reflected in the UN’s Global Fund, which gave direct representation to industry and 
nongovernmental organizations.195 In 1993, the WHA called on the WHO to mobilize and 
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encourage support of partners from nation states, nongovernmental organizations, and private 
sector entities for health development. This was part of the implementation strategy for “Health 
for All by the Year 2000.”196  
The current period may be understood as a reaction to the previous stages, characterized 
by the entry of new actors and values into the international health field. Transnational disease 
spread, issues of public health security, and the need for improved global health diplomacy have 
challenged the Westphalian governance structure, a system upon which the WHO was built.197 
Westphalian sovereignty is the concept of nation-state sovereignty based on two things: 
territoriality and the absence of a role for external agents in domestic structures. States were 
considered the primary institutional agents in an interstate system of relations. Scholars of 
international relations have identified the modern, western system of international cooperation 
amongst states, multinational corporations, and organizations as having begun at the Peace of 
Westphalia in 1648.198 As acknowledged in chapter 2 of the thesis, contemporary forms of global 
governance have made a transition from the Westphalian approach. The IHR only covered 
diseases of interest to the great powers: cholera, plague, and yellow fever ("Asiatic diseases"). 
The WHO did not have the legal authority, under international law, to release information 
without the consent of the member state. In a globalized context, the regulatory processes and 
strategies of the WHO needed to transcend to a “post-Westphalian public health” approach to 
effectively respond to the issues faced today. This shift has resulted in a world order 
characterized by a combination of formal and informal sources of regulatory authority, policy 
suggestions, and mechanisms from nation-states, domestic and international non-state actors, and 
international organizations. Thus, today, both the dominant actors of the Westphalian system and 
the emerging actors (private sector, civil society, and philanthropic organizations) interact in 
complex ways.199 The transition has resulted in a system where global health issues have become 
a subject of concern for leaders and the public worldwide. Appointed as the WHO Director-
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General in 1998, part of the credit for this shift in governance routine in the WHO is attributed to 
the leadership of Gro Harlem Brundtland, too. She introduced a corporate culture into the WHO 
to make it less bureaucratic and more efficient. Individuals from the for-profit private-sector 
were recruited to assume important positions within the organization. Brundtland appointed 
Michael Sholtz, formerly with Ciba-Geigy and SmithKline Beecham (now GlaxoSmithKline), as 
head of Health and Technology of the WHO.200 This is an example of effective incorporation of 
the Acklesonian-Lapidian elements to the WHO’s governance architecture. The organization has 
always been dependent upon others for the achievement of its targets and goals.201 A variety of 
tasks and projects accompany partnerships such as negotiations, formal-informal consultations, 
discussions with corporations and their business associations, co-regulatory arrangements to 
implement voluntary (legally non-binding) codes of conduct, and corporate social responsibility 
projects, many of which are cause-related marketing or other strategic sponsorship projects.202 
Partnerships are not a recent development in the WHO. The organization has long collaborated 
with the pharmaceutical industry toward the discovery, development, and distribution of drugs. It 
has also been involved in channelizing funds for certain research projects and enhancing the 
medicine market.203 One of these projects, the Special Program for Research and Training in 
Tropical Diseases (TDR), was established in 1975 by the WHO, UNDP, and the World Bank. 
TDR was clearly a public sector initiative, but it could not achieve some of its specific goals and 
targets, especially with respect to drug development and delivery, without the participation of the 
private sector. Hence, it collaborated with the pharmaceutical sector on certain aspects of the 
program.204  
There are several differences between the old and more recent partnerships. Recent 
ventures involve more money, including large donations from private foundations. The private 
sector is also more engaged in the existing governance structures and policy-making 
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initiatives.205 The health sector, amongst others, has seen the heaviest proliferation of PPPs over 
the past few years. Due to budget constraints, the WHO has entered into partnerships with the 
business sector that have enabled it to not only leverage its own resources, but also access new 
resources in order to fulfill its mandate. Currently, the annual budget of the WHO is estimated to 
be US$1.7 billion and total global expenditure for health is approximately US$4.1 trillion.206 The 
WHO tends to enter into partnerships that have well-defined and specific health outcomes such 
as those that are disease or risk-factor oriented. The basis of these partnerships should 
complement the ethical values and missions of the WHO. These collaborations will bring 
entrepreneurial talent and a business culture into the WHO, which may improve the 
organization’s efficiency.207 The WHO has initiated two approaches to regularize its processes of 
work with the non-state actors. Similarly, the business community may also adopt and endorse 
norms and values that the WHO advocates in relation to workers’ rights or to occupational 
health.208 A relevant PPP must fulfill the following WHO requirements for it to be integrated 
with the organization: it must be aligned with the WHO’s priorities, and must offer an innovative 
approach to achieve results that cannot be achieved by more traditional means. PPPs frequently 
evolve from an informal network to a formal operational one. Despite their lack of expertise in 
policy-making, PPPs have demonstrated their value in areas where the public sector has proven 
inefficient (e.g., in research and development, manufacturing, and marketing).209 The past two 
decades have witnessed the emergence of the Acklesonian and Lapidian elements of governance 
structure in the WHO. The engagement of the WHO with non-state actors and private sector 
entities is not only a result of pressure from its constituent nation states, but also the result of the 
organization’s desire and conviction to regain authority, legitimacy, and effectiveness in today’s 
market-oriented world.  
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 The role of NGOs, private foundations, and intermediaries 
Article 71 of the WHO constitution states that the WHO may make arrangements for 
consultation and cooperation with NGOs in carrying out its international health work.210 It is 
essential for the WHO to coordinate and interact with other inter-governmental organizations, 
national health institutions, and NGOs in order to avoid conflicts among the various actors at all 
levels of operation.211 Joint programs help to manage overall resources, and avoid the duplication 
of schemes and projects. The WHO has a long history of involvement with NGOs and civil 
society in their programs and projects. The objective of the WHO's collaboration with NGOs is 
to promote policies, strategies, and programs derived from the decisions of the organization's 
governing bodies, as well as put together programs, and to achieve harmony in balancing the 
interests of the various sectoral bodies.212 The NGOs benefit the WHO by assisting in its 
campaigns and projects at multiple levels, especially at local community level. The main 
criterion for admission into the office of the WHO requires that an NGO’s area of expertise be 
within the purview of the WHO. The ethics and principles must be in accordance with those of 
the WHO and should be non-commercial in function.213 The number of NGOs admitted into 
authoritative relations with the WHO has been increasing over the years, with 26 in 1951, 68 in 
1966, 125 in 181, 184 in 1996, and over 250 in 2008. There is a diverse range of expertise that 
the NGOs cover, ranging from science to medicine, social/humanitarian work (e.g., Lions Clubs, 
Rotary International, International Committee of the Red Cross, Save the Children Fund etc.), 
and environment (International Union for Conservation of Nature and Natural Resources etc.).  
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Figure 2. Number of NGOs admitted into the WHO over the years 
 
The WHO recognizes only one category of formal relations, known as official relations, which 
incorporates those NGOs that meet the criteria described in the “Principles Governing Relations 
with NGOs.” All other contacts, including working relations, are considered informal.214 The 
policy relations of the WHO with NGOs may start off as informal, involving exchange of 
information based on common interest with a reciprocal participation in technical meetings. 
There is no written agreement before the meetings. The meetings eventually culminate in a 
possible collaboration for developing medical and other standards, publication of scientific 
documents, collection of data for setting up a specific program, and also for planning research.215  
Partnership brokers operate as active links or intermediaries between different 
organizations and sectors (public, private, and nonprofit groups) that aim to collaborate as 
partners in a sustainable development initiative.216 In most cases, external donors and individual 
organizations or NGOs, as well as private foundations like the Bill and Melinda Gates 
Foundation and the Rockefellers Foundation play the broker’s role. Knowledge brokers—the 
people who bridge the gap between the producers and users of knowledge—are well-known for 
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their role as intermediaries in putting research results into policy and practice. They can function 
on behalf of the public sector or the private sector. Historically, brokers in multi-sector 
partnerships have played a critical role in process management and behind-the-scene leadership 
for the benefit of potential partners.217 The concept of brokers is slowly gaining ground in the 
health sector due to the surge in health initiatives and partnerships. For example, the Global 
Forum for Health Research helped to broker and facilitated the founding of some of the public-
private partnerships, such as the Medicines for Malaria Venture. The Bill and Melinda Gates 
Foundation is another very good example of a broker/collaborator. It donates enormous amounts 
of grants to partnerships, making it attractive for the private companies to partner with. The 
private foundations function to bring different parties together for a discussion and then motivate 
the partners to collaborate by offering predictable funding and a businesslike approach to the 
projects.218  
See table 5 for a discussion on the merits of partnerships for the WHO. 
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Table 5. Effect of partnerships on the working of the WHO219,220  
Functions and 
responsibilities 
 Enabling attributes Partnership merits  
• Acts as the world health 
authority. 
• Membership of 193 
member states.  
• Constitution which 
specifies health for all 
as a primary objective. 
• Industry tends to abide by 
the principles of health 
for all and other missions 
of the WHO.  
• Drugs and funding in 
health resources are more 
easily accessible.  
• WHO has increased 
access to knowledge, 
resources, and expertise 
from the private sector 
and the NGO community. 
• Formulates regulations 
and standards in global 
health. 
• Universal membership 
• Impartial approach to 
decision-making 
• Technically sound staff 
and networks. 
 
• Public and private sectors 
more apt to cooperate 
• Civil society and private 
sector members more 
likely to adhere to rules 
and standards as they 
participate in policy-
making. 
• Promotes and creates 
facilities for R&D and 
diagnostics. 
• Controls transnational 
spread of pathogens  
• Controls trade in illegal 
substances. 
• Aids in information 
dissemination, capacity 
building, and training 
for health personnel in 
member states.  
 
• Funded and supported 
by member state 
governments and 
private donor 
foundations. 
• Additional partners 
become involved in 
health development. 
• Number of R&D projects 
in the field of vaccine and 
drug production increases 
along with improved 
diagnostic techniques.  
• Private companies are 
compelled to develop 
ethically. 
• Global health security 
becomes more robust. 
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 Conclusion 
Looking at the transition of the WHO’s evolution over the last 60 years, one can argue 
that it has been robust in certain aspects and weak in others. However, the WHO is extremely 
important, especially for the poorest sections of the world. While there are numerous global 
health institutions, it is the sole multilateral institution with the legitimacy and authority to 
promote and protect world health. The WHO achieved milestones in successfully eradicating 
smallpox in 1980 and establishing the Framework Convention on Tobacco Control (FCTC) in 
2003.221,222 With respect to polio eradication, the WHO Western Pacific Region is now the 
second in the world to be certified as polio-free (after the WHO Region of the Americas in 
1994). However, the WHO has faced tremendous challenges in the Malaria Eradication Program, 
AIDS initiatives, and “Health for All” strategies. The organization began to lose its position as 
the world’s prominent leader in health, as non-governmental organizations and other UN 
agencies began to play an important role in shaping international health policy. In the 1990s, the 
recognition that disease prevention and good public health management is motivated by 
economics and trade broadened the WHO’s strategic vision and thinking. The intersection of 
health issues with economics and trade security has led the public health community to engage 
with players from diverse backgrounds. This pushed the organization to revamp its governing 
framework substantially and break away from the conventional mold of bureaucratic functioning. 
Gro Brundtland, who assumed office in 1998, played a crucial role in bringing about internal 
transformations and raising its profile internationally. She reduced the number of political 
appointments and increased the involvement of private players in governance structure.223 In 
facing the current budget crisis, the WHO has been forced to become increasingly reliant upon 
private sources of financing and public-private partnerships. The creation of global health 
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initiatives and partnerships is a part of the ongoing process of revision. See table 7 for the list of 
PPPs initiated by the WHO. 
Table 6. List of public-private partnerships initiated by the WHO 
1. Global Alliance to Eliminate Lymphatic Filariasis 
2. Global Fund to Fight AIDS, Tuberculosis and Malaria 
3. Global Fire Fighting Partnership 
4. Malaria Vaccine Initiative 
5. Medicines for Malaria Venture 
6. Roll Back Malaria Partnership 
7. Stop Tuberculosis Partnership 
8. The Partnership for Maternal, Newborn and Child Health 
9. UNAIDS/Industry Drug Access Initiative 
10. Global Polio Eradication Initiative 
Source: Adapted from Reich, Michael, James E. Austin, and Kent Buse. Public-Private Partnerships for Public 
Health. Harvard University Press, 2002. 
 
GAVI and TDR can be regarded as exemplary partnership-driven initiatives by the WHO. 
GAVI’s primary objective since its establishment in 2000 has been to increase poor countries’ 
access to immunization.224 TDR, established in 1975 and executed by the WHO, helps to 
coordinate, support, and influence global efforts to combat a portfolio of major diseases among 
the underprivileged. TDR is a diverse program that indulges in partnerships and networks at all 
levels.225 The MDP is another successful partnership in health and can be considered as a 
possible PPP model for addressing problems confronting international health.226  
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The purpose of the WHO’s work is to improve people’s lives, reduce the burdens of 
disease and poverty, and provide access to responsive health care for all. In spite of being the 
lead agency in health, it is important to recognize that the global health agenda is too broad for 
the organization to address alone.227 By adhering to the widely endorsed guidelines on 
collaboration within the commercial sector, the WHO can maintain its integrity and legitimacy, 
while still making a valuable contribution towards partnerships.228 This chapter demonstrated 
that the WHO over time has embraced all the three of the Ackleson-Lapid elements of 
governance (i.e., formal-informal policy actions, public-private partnerships, and actions at 
multiple levels). In spite of the numerous criticisms for involvement of non-state actors in 
governance (i.e., public-private partnerships) incorporation of all three elements by the WHO is 
evident. The next chapter will delve further into some key partnerships that the WHO has been 
part of. The chapter will also include a comparative review of both successful (MDP and TDR) 
and unsuccessful ventures (the “3 by 5” initiative and the Malaria Eradication Program) that will, 
hopefully, work to justify the value of Acklesonian-Lapidian elements of governance in 
international health. 
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Chapter 4 - Selected Projects of the WHO: the adoption of the 
elements of governance 
Soon after her appointment in 1998, Gro Brundtland, the Director-General of the WHO, 
called for open and constructive relations with the private sector and civil society.229 This chapter 
will review a few selected initiatives and projects, the WHO has been involved with, such as the 
MDP, TDR, “3 by 5” initiative, and the Malaria Eradication Program (MEP). It will hel  analyze 
the significance of partnerships, multiple players, and the method of formal-informal policy 
formulation in any international health initiative. Partnerships can be called a reflection of 
globalization. Thus, an international organization like the WHO is expected to cooperate globally 
across national governments, private industries, and civil society, while implementing actions 
locally. 
 Mectizan Donation Program (MDP) 
The Mectizan Donation Program is a partnership involving partners from diverse 
backgrounds. The Mectizan Donation Program, partnered with the Task Force for Global Health, 
was established more than 20 years ago in 1987 to oversee Merck & Co., Inc.'s donation of the 
drug ivermectin popularly called Mectizan, for the control of onchocerciasis worldwide.230 The 
MDP’s continued sustainability is attributed to cooperative partnerships that have created the 
program. The program is regarded as one of the longest running successful partnerships. It will 
be helpful to delve into the program’s functioning and actions at various levels to assess the 
reasons for its success as a model for PPPH. The prime partners that make this partnership 
include the pharmaceutical industry (Merck and GSK), NGDOs (the Carter Foundation, Hellen 
Keller International amongst others231), and international organizations {WHO, World Bank, 
CDC, African Program for Onchocerciasis Control (APOC), and Global Alliance to Eliminate 
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Lymphatic Filariasis (GAELF).232 In the mid-1970s, Merck discovered the drug, ivermectin. The 
WHO demonstrated the drug’s favorable safety profile and efficacy in humans, after 7 years of 
clinical trials with assistance from TDR. There was much deliberation and debate over donating 
the drug outright. Initially, Merck thought that the WHO, governments of affected regions, 
international health agencies and charitable foundations would come forward to purchase and 
distribute the drug to the deprived. This would help the company to sell the drug at a subsidized 
rate and have it distributed to all who could not afford it. However, due to limited budgets for 
health care, few were interested in donating and distributing the drugs.233 Merck asked the WHO 
to form a partnership with it to distribute ivermectin to the affected areas. The WHO, skeptical of 
the drug, was also unsure about its own legal ability to build a partnership with a private 
company. The constitution states that “the WHO may make suitable arrangements for 
consultation and cooperation with non-governmental international organizations,” but it does not 
specify anything about industry involvement.234 The WHO was also concerned about the degree 
of control it could exert in the whole process. Such collaboration was uncharted territory for both 
the WHO and Merck. Both the WHO and Merck were concerned about making negative 
assessments of individual governments’ capacities to implement treatment programs. After 
nearly 9 years, Dr. Roy Vagelos, the then CEO of Merck, decided that drug donation was the 
right course of action.235 TDR/WHO viewed the drug as an effective tool for containing 
transmission of onchocerciasis and reduction of prevalence at large. In 1987, Merck invited Dr. 
William Foege to the donation effort.236 He was asked to oversee the committee of experts. 
In 1998, Merck expanded the mandate of the program to include lymphatic filariasis 
elimination through the co-administration of Mectizan and Albendazole, donated by 
GlaxoSmithKline, in African countries and Yemen where lymphatic filariasis and 
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Onchocerciasis are co-endemic. SmithKline Beecham joined forces with Merck and pledged to 
donate albendazole free of charge to the WHO for use by governments and other collaborating 
organizations until lymphatic filariasis is eliminated from the world as a public health problem. 
Currently, more than 70 million treatments are approved for onchocerciasis in Africa and Latin 
America and 80 million for Lymphatic Filariasis in Africa and Yemen each year.237 Since the 
MDP’s inception in 1987, Merck has donated 1800 million tablets of Mectizan, with 530 million 
treatments for onchocerciasis administered. The program currently reaches 68 million people in 
Africa, Latin America, and Yemen annually, and via community-based treatment programs in 
125,000 communities in 33 endemic countries.238 The MDP has managed to involve numerous 
partners from heterogeneous backgrounds. It relies heavily on informal mechanisms and 
discussions to get the program moving. The WHO continues to play a leading technical role, 
while the World Bank is a major financial resource. The NGOs working in the area of river 
blindness prevention throughout Africa have faithfully distributed ivermectin to the population in 
need. By working along with ministries of health, they help mobilize funds, ensure all 
communities are treated, and monitor, evaluate and report on the programs.239 The program is a 
good example wherein there has been both formal, as well as informal, methods utilized to attain 
objectives. As the program approaches its 25th year of operation, the potential to eliminate both 
diseases is feasible.240 The partnership is regarded very highly on aspects of governance and 
management, with only a few problems identified. It has been able to involve a wide array of 
partners through informal mechanisms that rely on goodwill and reciprocity. The reasons for the 
sustained success of the program can be listed due to various reasons.241 With the drug being 
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prescribed only as an annual dose, it was best suited for mass distribution. The Mectizan Expert 
Committee, consisting of public health experts and personnel from Merck and the WHO, 
provides technical guidance to the program. With this arrangement, the donor company keeps in 
close touch with the program, whilst ensuring that commercial interests do not interfere with 
operational decisions.242 The MDP’s delivery strategy accelerated by the WHO is performed 
effectively by community directed treatment of ivermectin. This has enabled communities to 
organize, direct, and manage their own treatment, with 125,000 communities now responsible for 
Mectizan treatment. There were well defined roles and responsibilities for all the actors involved 
at the onset of the project. The MDP managed to efficiently report back to key stakeholders 
regarding the organization’s direction and performance.243 It provided coordination mechanisms 
and engaged partners’ interest in its shared vision and mission. The reason for the sustained 
impact of the partnership is that the coordination mechanisms largely depend on informal 
interactions built on norms of trust and cooperation, rather than by formal contracts, or 
ownerships of assets by a single firm that provides ivermectin distribution services. Through this 
program, Merck made unequivocal commitment to donate Mectizan (ivermectin) for as long as 
needed and wherever needed, to combat this disease.244 
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Figure 3. The Structure of the Mectizan Donation Program  
Source: Peters, D. H., and T. Phillips. "Mectizan Donation Program: Evaluation of a Public-
Private Partnership." Tropical Medicine & International Health 9, no. 4 (2004). pp-A5 
 
The program has been lauded for its ability to clearly define roles and responsibilities, be 
ethical, and balance responsibility between countries and partners. Merck endorses partnerships 
because it believes that pharmaceutical companies have a responsibility to offer assistance when 
social, political, and economic conditions make it impossible for patients to receive life-saving 
therapies, and that Merck and others should leverage their expertise to help remove the barriers 
that stand between patients and the therapies they need.245 
Special Program for Research and Training in Tropical Diseases (TDR) 
Responding to the demands of the health situation in the 1970s, the WHO in 
collaboration with the UNDP and World Bank, established the Special Program for Research and 
Training in Tropical Diseases (TDR). The program aimed to develop safe and affordable means 
of diagnosis and treatment. It also sought to strengthen health systems and drug delivery in the 
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developing countries. The financial contributions to the program are provided by voluntary 
donations from governments, NGOs, as well as the three co-sponsoring organizations. TDR, 
through its co-sponsors UNDP, the World Bank, and the WHO, has access to technical expertise. 
It is based at the WHO headquarters in Geneva, Switzerland. TDR’s other co-sponsoring 
agencies work with the WHO to combine their expertise in an effort to improve the existing 
methods and to develop new approaches for the prevention, diagnosis, treatment, and control of 
neglected infectious diseases.246 The WHO plays a prominent role in the program as the 
Executing Agency of TDR, with all TDR staff coming from the WHO. TDR adheres to the 
WHO’s administrative rules and procedures. The program’s interaction occurs in a broad range 
of disciplines from governmental and non-governmental organizations to individuals at 
international and national levels. The structure of the TDR’s governing body consists of the 
following:247  
1. Joint Coordinating Board (JCB) – The JCB, created in 1978, is composed of 12 members 
selected by the resource contributors to the program, 12 government representatives 
chosen by the six regional committees of the WHO, six members representing other 
cooperating parties selected by the JCB itself, and the four co-sponsoring agencies.  
2. Standing Committee – It is comprised of senior representatives of the four co-sponsoring 
agencies, with ex-officio attendance from the chair and vice-chair of the JCB and the 
chair of scientific and Technical Advisory Committee (STAC).  
3. Scientific and Technical Advisory Committee (STAC) – It is composed of 21 leading 
health research scientists. The STAC reviews and evaluates all scientific and technical 
activities and makes recommendations on program activities, including the distribution of 
funds.  
TDR governance structure ensures equal representation of the donor and recipient governments 
on its governing body—the Joint Coordinating Board (JCB). TDR focuses on nine diseases: 
malaria, schistosomiasis, onchocerciasis, lymphatic filariasis, African trypanosomiasis, Chagas 
disease, leishmaniasis, leprosy, and TB. TB was included only in 1999. TDR began as an 
exclusively public sector initiative. However, the program could not meet some of its specific 
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goals and objectives, especially the development of new drugs, without the participation of the 
private pharmaceutical sector.248 Merck & Co., Inc. and SmithKline Beecham pharmaceuticals 
were the prominent participators amongst the ten other companies. Interactions with the private 
sector have resulted in an immense scientific contribution from the pharmaceutical industry, 
more effective delivery of specific services, and the creation of joint programs within TDR to 
address certain diseases. In the mid 1980s, many scientists from the private sector began 
participating in TDR’s scientific advisory committees, something that was perhaps unparalleled 
in other global public health institutions.249 TDR’s primary objective included the improvement 
and development of existing and/or new approaches preventing, diagnosing, treating, and 
controlling neglected infectious diseases. It also sought to strengthen the capacity of developing 
countries and to undertake the research required for developing and implementing new and 
improved disease control approaches.250 Thus, in order to fulfill these objectives, TDR had 
helped build dynamic “virtual” networks of researchers and research institutions that are widely 
dispersed worldwide. The program has assumed a substantial role as a leader, as well as a 
catalyst in initiatives for drug development, diagnostics, genomics, clinical evaluation, and 
biological screening. The unique feature of the program is the involvement of distinguished 
scientists from all over the world—from both developed as well as developing nations, from 
academia, research institutes, industry, as well as health departments.251 TDR values science over 
political agendas, and provides a neutral platform where scientists from all over the world can 
work together. The scientists, however, are not appointed as representatives of their respective 
companies in the TDR.  
One of TDR’s key values and organizational beliefs has been to forge partnerships in 
order to relieve the poor from neglected diseases; improve research and planning in agencies at 
international, national, and local levels; and close the global gap in research and development.252 
This approach echoes the value of the incorporation of the three elements of governance to reach 
the organization’s goals and objectives. TDR was one of the first programs of the WHO to 
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engage with the private sector in public-private partnership activities, long before PPPs became a 
popular institutional model in health. TDR catalyzed the creation of the first formalized PPPs for 
health research such as the Medicines for Malaria Venture (MMV) and the Foundation for 
Innovative New Diagnostics (FIND).253 TDR, being increasingly results oriented, has and will in 
the future take advantage of the numerous of networks and groups of stakeholders, to expand its 
brokerage role in this complex environment. 
 Achievements 
TDR has worked with the industry for clinical evaluation of new drugs such as 
mefloquine (Hoffman la Roche), ivermectin (Merck), and elfornithine (Hoechst Marion Roussel, 
Inc). Ivermectin has now become the source of one of the most successful drug donation 
programs, the Mectizan Donation Program.254 In 2004, genome sequencing of Anopheles 
gambiae was completed by a TDR-fostered consortium and the drug Coartem was approved for 
use against malaria in infants and young children who weigh more than 5 kg.255 TDR has played 
an important role in the generation of knowledge about the genomes of the parasites that cause 
African trypanosomiasis, Chagas disease, leishmaniasis, schistosomiasis, and lymphatic 
filariasis, and is now focusing on providing capacity to utilize the parasite genome data and in 
supporting developments in applied genomics and bioinformatics.256 In the last decade, TDR has 
continued to play a part in the registration of certain new drugs and tools, while in other cases 
drug-development projects were transferred to new PPPs. TDR helped develop and launch the 
Medicines for Malaria Venture (MMV) in 1999, and supported the creation of the Global 
Alliance for TB Drug Development in 2000 and the Drugs for Neglected Diseases initiative 
(DNDi) in 2003. TDR has made greatest progress in the elimination of the 5 diseases, namely 
leprosy, by widespread adoption of TDR-generated evidence recommending multi-drug therapy; 
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Chagas disease, by supporting epidemiological surveys, vector-control tools, and blood 
screening; onchocerciasis, through the introduction of ivermectin, community directed treatment, 
and introduction of the REMO (rapid epidemiological monitoring of onchocerciasis); and 
lymphatic filariasis, through development of a new one-dose drug regime, as well as diagnostic 
tools and strategies for mass drug administration; and visceral leishmaniasis, through joint effort 
with the MOH of India and Bangladesh to eliminate the disease as a public health problem from 
the Indian sub-continent by 2015.257 In its 30 years of existence, TDR has managed to fund over 
8000 projects involving 6500 scientists. These projects include US$300 million in grants for 
5300 research and development ventures in developing nations and US$117 million for 2700 
projects dealing with research strengthening and training in about 80 developing countries.258 
The TDR also plays an important role in clinical trials involving public-private consortia and in 
the management of drug development though product development teams (PDTs). These teams 
guide the overall development program, including timelines, budget, study design and protocols. 
They comprise of pharmaceutical company experts, TDR members, clinical investigators and 
other external experts.259 
TDR has defined goals for the future: research on neglected priority needs, 
empowerment, and stewardship. TDR’s key strength is its ability to work in partnerships and 
alliances. Such partnerships have provided TDR with financial resources, political support, 
technology, tools, and expertise necessary for carrying out their research. This is reciprocated by 
the TDR by providing funding for the research, making available detailed reports of research and 
policy by engaging with the WHO policy-makers and translating the research into policy. TDR 
engages in different types of partnerships: technical partnerships, advisory partnerships, research 
equality assurance partnerships, and capacity-building partnerships. TDR represents the voice of 
not only the global public policy sector, but also of the disenfranchised populations around the 
world. 260 For TDR, partnerships and the incorporation of the three elements of governance has 
aided in access to expertise and resources that have produced a steady stream of new knowledge 
and effective technologies.    
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 The “3 by 5” initiative 
In recent years, an international consensus has emerged on the need to fight HIV/AIDS 
with a comprehensive response including treatment, care, prevention, and impact mitigation. In 
response to these opportunities and urgency the AIDS pandemic demanded, the WHO and 
UNAIDS released the “3 by 5” initiative in December 2003, a strategy that was aimed at 
providing antiretroviral treatment to three million people living with AIDS in developing 
countries and those in transition by the end of 2005. It was a global target endorsed by 192 
countries at the WHA held in May 2004.261 Like its early mass treatment top-down campaigns 
for malaria eradication, small pox, and leprosy, the WHO took a leading role in the 
implementation of the “3 by 5” program as well. The figure of 3 million represented only about 
half of the estimated number of AIDS patients worldwide in need of antiretroviral therapy 
(ART). By the end of 2005, the initiative achieved less than half of its stated goal. Despite 
achieving marginal success, the initiative failed to reach its target.262 Approximately 1 million 
people received treatment, which fell short of the milestone of 1.6 million set in the “3 by 5” 
strategy for June 2005.263 The “3 by 5” initiative was an unrealistically ambitious project. 
Partnerships and effective collaboration at both country and international levels were absolutely 
essential for accomplishing the initiative. The challenges and limitations that the initiative faced 
were  
• lack of political commitment 
• inadequate financial resources  
• lack of coordination among multilateral institutions, international donors, and financial 
partners 
• unskilled human resources 
• lack of enough drugs and use of under-qualified drugs 
• decline in preventive measures 
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• inequitable access to the drugs 
• dominance of the WHO’s administrative procedures 
One of the major problems of the WHO’s “3 by 5” campaign involved drug quality and 
management. In their effort to get as many people on treatment for as little cost as possible, the 
WHO pre-qualified non-FDA approved triple-drug therapies supplied by generic 
manufacturers.264 The project was hurried and functioned erratically. The initiative involved 
resources and assistance from the non-state actors (private sector and NGOs), but their roles 
were not well defined and well coordinated. The WHO could not boast solid collaborations with 
the pharmaceutical sector for the initiative. The “3 by 5” target was based on what could be 
achieved if countries, donors, and international agencies were fully successful in expanding 
political will, mobilizing funding resources, and building health infrastructure and systems. The 
venture lacked a strong nexus of stakeholders involved with it. The coordination was highly 
disorganized which also resulted in wastage of funds or inequitable allocation of funds. One of 
the other problems that confronted the WHO was that there was an overlap of previous 
HIV/AIDS initiatives being carried out simultaneously along with the “3 by 5” initiative in 
several member nations. The venture is an example of ineffective and incomplete 
implementation of the three essential elements of governance that the thesis has reiterated.265  
 The Malaria Eradication Program (MEP) 
Malaria was the first disease the WHO tried to eradicate in the 1950s, and it was also 
WHO’s first failure at global eradication. The concept of malaria eradication was first proposed 
in 1947, when an interim commission of the WHO convened an expert committee on malaria. In 
1955, the WHA decided for the WHO to implement the program, and it was launched under the 
leadership of noted malariologist Dr. Emilio Pampana.266 The strategy focused on reliance on 
spraying of DDT (dichloro-diphenyl-trichloroethane) and treatment with antimalaria drugs, 
notably chloroquinone. MEP recruited teams at inter-country and inter-regional levels to assess 
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the development of the eradication program in different countries and undertake diagnostic and 
epidemiological studies. The program enjoyed some initial success, achieving eradication in 65 
countries by 1960.267 Eradication was achieved in industrialized nations in Americas, Asia, and 
Africa. In 1964, the campaign covered two-thirds of population exposed to the disease. However, 
from late 1950s onwards, the feasibility of the total eradication was questioned. A 1982 WHO 
report suggests that 365 million people were living in areas where malaria was endemic and 
where no specific anti-malaria measures were carried out. About 46% were still in endemic zone, 
where some measures were implemented. Numerous technical and operational problems were 
acknowledged by the WHO in the MEP: 268  
1. inadequate health services 
2. financial constraints  
3. incoherent planning  
4. over reliance on DDT (coupled with impact of the growing resistance to vectors to 
residual insecticides)  
5. lack of motivation for developing improved drugs and insecticides 
6. insufficient knowledge about essential antimalarial drugs at community level  
7. inadequate distribution of drugs 
8. shortage of trained personnel  
Expenditures for the WHO kept rising each year from its inception, largely because many 
of its large-scale disease eradication programs took longer than originally anticipated. From 
1957-1967, the WHO spent over US$1 billion on the MEP. After spending an additional US$1.2 
billion from 1967-1975, the WHO realized that that it was unrealistic to sustain funding for a 
complete eradication, and in 1975, the program’s objective was converted from malaria 
eradication to malaria control. Many of these problems stemmed from the fact that the disease 
had developed resistance to both chloroquine and DDT.269 The problems of resistance to 
insecticides and the evasive behavior of vectors became more widespread and evolved more 
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rapidly than expected. Despite the loopholes and ineffectiveness of the drugs and insecticides, 
the WHO did not resort to high quality research & development to produce improved 
antimalarial products. The WHO believed that further research was unnecessary, and that 
eradication required a rigid discipline in which local deviations from a centrally defined plan 
must be prevented. Hence, MEP did not boast of any particular private pharmaceutical sector 
involvement in its research & development, operation, and administration. The funds mainly 
came from the UNDP, UNICEF, and UNAIDS.270 Realizing that the organization had failed to 
achieve its original objectives, the focus and direction of this MEP was re-evaluated and 
converted into a control program in 1969. Recognizing the duration of time the MEP would take, 
UNICEF and other major collaborating agencies withdrew their support from the malaria 
program in favor of general health programs. Although planning was considered the strong point 
of the MEP at its outset, the planning was unsystematic and lacked vision.271 The WHO admitted 
that insufficient attention was given to modern management techniques. There were inadequacies 
and gaps in all their original plans of operation. MEP did not have a schedule in place. There 
were only unrealistic claims being made about it achieving total eradication. The programs in 
individual countries lacked many of the requirements of epidemiological knowledge and 
administrative organization which were overlooked because of the humanitarian appeal and 
urgency.272 The MEP coordination occurred at three levels of command: central, intermediate, 
and peripheral. Despite operating at multiple levels, the program did not involve civil society or 
the NGO community who assist in staff training, surveillance, awareness, drug distribution etc. 
The program lacked designation of well defined functions for each member involved. Moreover, 
the major players included only the WHO, its regional offices, and the respective national 
governments. The narrow-minded vertical approach contributed to the failure of the campaign. It 
is evident that MEP was ineffective due to its execution under constrained and government 
administrative procedures.273 Communities should be encouraged and supported to adopt malaria 
elimination as their own goal, reporting abnormal situations, and creating a demand for 
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effectiveness. Their support can be harnessed by involving skills and expertise of the local 
NGOs. Analyzing the drawbacks and reasons for the drawbacks, this thesis arrives on the 
conclusion that MEP did not embrace the three elements of governance in its structure. The 
implementation of the program was seen at multiple levels of the society, but execution of the 
program lacked collective action. The venture lacked professionalism and focused on the end 
result rather than the process leading to the final objective. See table 7 for a comparative analysis 
of the successful and unsuccessful initiatives discussed in this chapter. 
 
Table 7. Comparative review of the attributes of the four initiatives 
TDR and MDP MEP and “3 by 5” initiative 
1. Based on public-private partnerships at 
the international, national, and local 
levels (involvement of pharmaceutical 
industry, World Bank, WHO, 
Ministries of Health, local 
communities, and non-governmental 
organizations)  
1. Lack of solid partnerships among 
governments, private sectors, and 
NGOs 
2. Comprised of concrete goals and 
objectives (congruency of mission, 
strategy, and values among all partners) 
2. Incoherent planning coupled with 
disorganized and erratic functioning  
3. WHO not the sole authority or the only 
representative of the initiative 
3. WHO was the authority and leader of 
the initiatives 
4. Long term commitment from the 
stakeholders 
4. Lack of commitment from stakeholders 
5. Community-based mass treatment 
programs harnessing skills and 
expertise of local NGOs 
5. Top-down strategies with lack of NGO 
and community participation 
6. Sustained financial contribution from 
the partners (direct costs to the 
organizations have been minimal) 
6. Funded by UN agencies and 
withdrawal of funding and resources 
from the agencies when no progress 
was noted 
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Lessons learned from the MEP and the “3 by 5” initiative highlight the fact that no single 
strategy or government administration procedures can be applicable everywhere. No venture 
should be rushed head-long into without considerable planning. The WHO entails long-term 
commitment with a flexible strategy exhibiting community involvement, integration of health 
systems, partnerships, and the development of agile surveillance systems.274 Ensuring global 
access to advances in science and health technology, development and distribution of lifesaving 
drugs, requires effective leadership and public-private partnerships.275 Partnerships with the 
private sector have demonstrated an ability to advance public health messages and create 
incentives for the industry to develop healthier products.276 The WHO’s major task is to combat 
illness—especially key infectious diseases that ravage the world’s poor—but a long-running 
dispute over the preferred approach has left the organization divided and ineffectual in many of 
its projects. Multi-member partnerships, which have recently become popular, reflect recognition 
that some problems require many partners and complex organizational mechanisms to address all 
the different aspects.277  
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Chapter 5 - Conclusion 
Globalization is generally understood to include two interrelated elements: the opening of 
borders to increasingly fast flows of goods, services, finance, people, and ideas across 
international borders; and the changes in institutional and policy regimes at the international and 
national levels that facilitate or promote such flows.278 It is one of the major causes that have led 
to “organization explosion” and the resulting proliferation of associations and networks at every 
level of the community.279 Globalization has provoked shifting of boundaries, relocation of 
authorities, weakening of states, introduction of new players in bureaucratic decisions, and an 
upsurge of NGOs and private sector actors.280 The evolution of species, antimicrobial resistance, 
and even the influence of media are all creating new health challenges, making the health risks 
evident. Health advances or setbacks in one part of the globe impact health worldwide. The 
tremendous interaction and interdependence between various players requires efficient 
networking coupled with cooperation and planning. The departure from traditional forms of 
authority encouraged the author of this thesis to focus on the processes of governance, rather 
than on governments as the entities exercising authority. The advent of new partnerships, new 
market systems, and new instruments offers promising solutions to the global health 
challenges.281 The governance debate is complex; however, this thesis endorses the Acklesonian 
and Lapidian definition for governance that comprises a formal and informal coordination—
across multiple levels from the local to the global—among public agencies and private 
corporations seeking to accomplish common goals and resolve problems through partnerships 
and collective action.282 Governance refers to a set of institutions and actors that are drawn from 
within and also beyond government. It recognizes that the capacity to “get things done” which 
does not rest solely on the power of government to command or use authority.283 
Partnerships between public/governmental entities, private/commercial entities, and civil 
society contribute to improving health worldwide by combining different skills and resources of 
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various sectors in innovative ways. The number of such formalized public-private partnerships 
has increased dramatically in the recent history, from about 50 in the 1980s to more than 400 
today, according to a survey reported by Kaul.284,285 The public health sector is confronted by 
formidable challenges which need global collective solutions. All stakeholders need to recognize 
the objective of supporting and improving everyone’s health. The WHO is an international 
organization formed for the purpose of fostering international cooperation in the health field. 
However, the organization has experienced a complex landscape of competing ideas, interests, 
and institutions. The foundation on which the organization’s governance structure was 
established called for interaction at multiple levels of society to achieve its mandate of health for 
all. Their ambition, agenda, declarations, and programs have an international scope, but their 
implementation is national as the WHO acts in agreement with the national governments.286 The 
WHO has established collaboration centers that participate on a contractual basis in cooperative 
programs supported by the organization at the national, international, regional, interregional, and 
global levels. The WHO has a long history of relations with NGOs (both officially and 
unofficially). The constitution mandates that the WHO may make suitable arrangements for 
consultation and cooperation with nongovernmental organizations (NGOs) in carrying out its 
international health work. During the 1960's and 70's its direction was more influenced by 
political events than it was by technical interventions. The financial deficit was immense and the 
organization was relying on voluntary contributions. The intensification of globalization in the 
1990s renewed debates about the WHO’s mandate in international health security and health 
cooperation.287 Multilateral institutions such as the World Bank and IMF displaced the WHO as 
a major influence behind health policy in poor countries because of their greater funding power. 
Additionally, in the late 1980s and early 1990s, the WHO was accused of lack of direction and 
cohesion, reluctance to move beyond prevention of infectious diseases, and reluctance to become 
involved in the affairs of national governments.288 The appointment of Kofi Annan as the UN 
Secretary-General in 1997 was one of the major turning points that encouraged the shift from an 
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anti-business approach to a pro-business approach within the UN and its agencies. Kofi Annan, 
with his business education, brought with him an understanding and appreciation for the private 
sector that none of his predecessors had displayed. It was a departure from the traditional 
diplomatic background of every UN Secretary-General.289 Thus, it is vital to address if the WHO 
has been able to establish a framework wherein member states, civil society, and private actors 
are able to embrace the new global health governance agenda. It is possible to distinguish and 
elucidate reasons for the transition in the WHO’s governance structure to encompass the 
Acklesonian and Lapidian system into its operation.  
 
Table 8. Reasons for transition in the WHO governance structure  
Reasons for the transition: 
Lack of resources 
• Inadequate organizational resources to carry out basic mandates 
• Poor management of funds   
• Dwindling financial assistance from the member states 
Inefficient leadership290 
• Misplaced priorities (political gain over technical excellence) 
• Widespread cronyism 
Bureaucracy 
• Disparate and uncoordinated structure; fragmented and decentralized 
power 
• Internal strife 
Reliance on national governments 
• Inability to act independently of member states 
• Lack of authority to directly intervene in member states’ health programs  
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Inability to keep up with other multilateral institutions and private foundations 
• Inability to adopt a “hard business approach” to generate funding 
• Excessive caution about forming partnerships with the private sector 
• Inability to adapt to shifting governance structures; legally restricted by an 
outdated constitution 
Underequipped to effectively combat/control new and reemerging diseases 
• Inadequate resources to address HIV/AIDS, SARS, neglected tropical 
diseases, chronic diseases (e.g., cancer), and resurging diseases (e.g., TB 
and malaria)  
• Lack of funding to conduct research for new drugs and vaccines 
• Unwillingness to partner with private pharmaceutical industry 
  
One of the major reasons for the transition was resource deficiency and financial strain on 
the WHO. The organization was ineffective in many cases because its organizational resources 
were inadequate to perform particular functions and efficiently solve problems. It forced the 
organization to take the route of multilateralism. Its working was too politicized and 
bureaucratic; despite the dedication of the many public health professionals employed, the WHO 
had a reputation of possessing a weak governance structure. The glacial pace at which the 
WHO’s bureaucracy operated ranked among the most frequently expressed criticisms of the 
organization, especially by the donor organizations. The inability of the WHO to provide health 
as a GPG has forced the need to foster the governance arrangements.291 These considerations led 
to the evolution of a range of interface arrangements that brought together two kinds of 
organizations: those with the mandate to offer public good, and those that could bring about 
public good through the provision of resources, technical expertise or outreach.292 The WHO has 
always been dependent upon national governments and private foundations for funding, and such 
dependence has often resulted in chaotic and political decision-making processes. The WHO 
resorted to forging alliances for R&D on drugs and vaccines for disease prevention. The 
worldwide HIV/AIDS epidemic strained health systems that were already overstretched. The 
turn of the millennium witnessed the proliferation of diseases like HIV, TB, infectious diseases, 
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and other global health problems which resulted in a fundamentally new approach to tackling 
them through public–private partnerships. After a decade of what was widely deemed uninspired 
leadership, Director-General Brundtland began her appointment with an overhaul, bringing in an 
almost entirely new senior staff and refocusing the WHO's mission. In particular, she 
strengthened the WHO's partnerships with member countries, non-profit groups, and even 
private-sector businesses to increase the agency's effectiveness. The Civil Society Initiative 
(CSI) fosters relations between WHO and nongovernmental and civil society organizations and 
is responsible for the administration of formal relations as set out in the principles governing 
relations between WHO and nongovernmental organizations (NGOs).293 In more recent years, 
the nonprofit sectors have grown in scale and influence and are having profound impacts on 
health.294 In 2007 the total funding for global health was US$22 billion, US$7 billion of which 
was provided by PPPs and private foundations. The development of new partnership structures 
for public health is an important goal of the WHO. The global health sector now leads the race, 
with steady increases in health partnerships with each passing year. The number of public-private 
partnerships for health grew rapidly, from 1 in 1982 to 33 in 1998, and then about 91 in 2003. 
The WHO and The United Nations Children's Fund (UNICEF) have been the two organizations 
most involved in these initiatives, participating in 42 and 19 such institutions respectively. See 
figure 5 for details.295 PPPs and informal networks are being increasingly encouraged as part of 
the comprehensive development framework, in an efficient, effective and equitable manner 
because of lack of resources and management issues.296  
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Figure 4. Trends in the number of public-private partnerships in health over time 
Sources: B, Liliana, and Andonova Goldfarb Center. "Globalization, Agency, and Institutional Innovation: The Rise 
of Public-Private Partnerships in Global Governance." (2006). Nishtar, Sania. "Public-Private 'Partnerships' in 
Health - a Global Call to Action." Health Research Policy and Systems 2, no. 1 (2004): 5. 
 
 
 
82 
The fact that three of the UN’s eight Millennium Development Goals (MDGs) are 
specific to health is evidence of the consensus on this point across the international development 
community.297 The eighth MDG calls for the “[development of] a global partnership,” which 
includes the development of partnerships to make affordable, essential drugs available in 
developing countries.298 As offspring of the UN, the WHO endorses the MDGs. However, in 
order for the WHO to effectively accomplish these goals, it is critical that it apply the 
Acklesonian-Lapidian elements of governance to its working framework over a continuous 
period of time. Over the past two decades, the WHO has come to recognize that while member 
states continue to be vital and active participants at the core of public affairs, they are no longer 
the only stakeholders who initiate programs and dominate the arenas of health security. The 
WHO, as the only global health actor possessing both democratic and formal legal legitimacy, is 
best positioned to capitalize on this new situation in public health and respond with innovative 
approaches to governance, moving away from traditional forms of governance. Such a 
transformation is already underway and is needed to bring the increasingly chaotic network of 
activities and entities affecting health outcomes under the umbrella of a centralized standard-
setting agency.299 In meeting the challenges of an aging population, infectious diseases, 
bioterrorism, and productive communities, the pharmaceutical industry is indispensable to the 
WHO. Leveraging partnerships and collaboration with the private sector to address the global 
health issues may not be easy. Dr. Margaret Chan, Director-General of the WHO (2006-present), 
in referring to the global health leadership, stated that, “ the WHO can no longer aim to direct 
and coordinate all of the activities and policies in multiple sectors that influence public health 
today.”300  
The WHO participates in a number of global public-private partnerships. Merck’s MDP, 
backed up by public and philanthropic sector provision of the necessary infrastructure to utilize 
this drug effectively for onchocerciasis control is a shining example of what can be achieved 
through positive cooperation among multiple stakeholders. Therefore, the different players stand 
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an improved chance of delivering on their objectives if they can find better ways of 
collaborating.301 While neither the public nor the private sector alone can eliminate health 
inequities, focused partnerships involving both sectors have the potential to contribute to their 
reduction. The WHO Special Program for Research and Training in Tropical Diseases 
(WHO/TDR) took over much of the burden in the 1990s, when it became clear that a new model 
was needed to stimulate the discovery and development of new medicines for tropical 
diseases.302 The success of the MDP and TDR initiatives justifies the incorporation of the three 
elements of governance in an organizational structure. However, long-term, successful 
implementation of those elements is critical. In comparing programs like the MEP and the “3 by 
5” initiative with the much more effective MDP, this thesis has arrived at the conclusion that it is 
essential to integrate administrative structure, as well as the patterns of operation for each 
national program, into the health and socio-cultural setting of the country. This will ensure better 
management of multiple levels of society. It is vital to acknowledge that public-private 
governance framework does not simply crop up where intergovernmental or state institutions 
have failed, as many arguments might imply. Instead, public-private institutions cluster in 
narrower areas of cooperation where the strategic interests of international organizations, states, 
and transnational actors intersect.303 
The WHO now has an opportunity to develop intellectual leadership in the 5 action 
areas:304 
• health as a global public good 
• health as a key component of collective human security 
• health as a key factor of global governance of interdependence 
• health as responsible business practice and social responsibility 
• health as global citizenship 
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Health as a GPG can be addressed only when individual governments come together, through the 
WHO, to create transnational policy and action. Proactive and committed actions from the 
different players are needed to provide health as GPG.305 Although the WHO has undergone 
tremendous modifications in its governance structure over time, today, the governance principles 
have emerged in a more complex manner than when the WHO was the only global leader in 
health. Thus there is a need for more coherence and coordination in global health. The challenge 
for the WHO is to provide an interface—polylateral diplomacy venue—where different 
institutions and stakeholders in global health can interact with one another. This thesis reiterates 
the Acklesonian-Lapidian definition of governance, and it puts forth suggestions to incorporate 
the following strategic pathways for superior and effective functioning of the WHO.306,307,308 
1. Providing mechanisms and instruments:  
The key task for the WHO in the current global health situation is identifying key 
stakeholders for each issue at hand, and developing effective partnerships among new 
global health actors, multilateral intergovernmental institutions, and relevant parties. 
Forging partnerships will help to promote cooperation among scientific professional 
groups, political groups, and civil society contributing to the advancement of health. 
Encouraging participation of non-state actors also relieves the WHO of some financial 
pressures. The WHO, through the new governance framework, brings financial stability, 
freedom, and advanced innovative solutions to solving problems that would be otherwise 
improbable through its lone efforts, offering a win-win situation for all the stakeholders 
involved.  
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2. Ensuring polylateral diplomacy:309  
It is important that the WHO provides an interface to conduct formal and informal 
meetings, where NGOs exert influence, the private sector lobbies, and agreements are 
eventually reached. The WHO needs to adapt to new decision-making procedures and 
create conditions for ordered rule and collective action. Such collective action helps to 
strengthen collaboration with all its member states and helps devise a broader strategy for 
reaching out to the world.  
3. Engaging in new influential ways:  
As health is a center point of geopolitics, security, trade, and foreign policy, the WHO 
needs to work closely with partner agencies and organizations to address social 
determinants of health and promote policy coherence in order to minimize health 
inequities and advocate these issues as top priorities for global development. It needs to 
come up with initiatives to confront major health threats such as population growth and 
the tobacco epidemic. There is a need for acceptance of health not only as an outcome of 
development, but also as a significant contribution to economic growth, health security, 
and social stability. The governance architecture should be multilayered, encompassing 
all levels of society (local, national, and international) in order to build community 
capacity and civic trust.  
Governance structures comprised of the three elements of governance allows the 
problem-solving burden to be distributed among the stakeholders. Partnership between the WHO 
and the commercial sector is inevitable, but risks and benefits need to be reflected upon. A form 
of governance based on the the Acklesonian-Lapidian defintion assists in accomplishing goals 
employing methods of shared decision-making and risk taking. It is important for the WHO to 
embrace the Acklesonian-Lapidian elements and grow from strength to strength by adhering to 
the strategies mentioned above. This will enable the WHO to act as a formal institution 
empowered to enforce compliance, and approve of informal arrangements that people or other 
institutions have agreed to or perceived to be in their interest. Incorporating these elements 
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within the organization will enable organized collectives of people and the institution 
representatives to speak in unison with one voice.310  
To quote the philosopher Arthur Schopenhauer, 
“Every truth passes through three stages before it is recognized. In the first, it 
is ridiculed, in the second it is opposed, and eventually is it regarded as self-
evident.”  
In keeping with these words, the author of this thesis believes that the value of the Ackleson-
Lapid definition for governance in health security will gradually become self-evident. 
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